NCT02555735
Exceptional Responders With Solid Tumor Cancer to Chemotherapy Not Available Not Available enrolling_by_invitation NCT00037804
Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction treatment 1 completed NCT02414724
Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors or Lymphoma treatment 1 terminated NCT02567396
Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction treatment 1 withdrawn NCT04147494
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues No drug interventions basic_science 0 recruiting NCT02867592
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors treatment 2 active_not_recruiting NCT01017640
Veliparib With or Without Mitomycin C in Treating Patients With Metastatic, Unresectable, or Recurrent Solid Tumors treatment 1 completed NCT03804255
Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting No drug interventions Not Available Not Available withdrawn NCT02142803
TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors treatment 1 active_not_recruiting NCT02188264
Selumetinib and Cyclosporine in Treating Patients With Advanced Solid Tumors or Advanced or Metastatic Colorectal Cancer treatment 1 active_not_recruiting NCT01749384
Tivantinib and Bevacizumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery treatment 1 completed NCT02713269
Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord No drug interventions treatment 2 active_not_recruiting NCT03098277
Movement Tracking Devices to Monitor Physical Activity in Patients Undergoing Chemotherapy No drug interventions other Not Available active_not_recruiting NCT00740805
Veliparib, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Non-Hodgkin Lymphoma treatment 1 active_not_recruiting NCT03834961
Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia treatment 2 active_not_recruiting NCT04060849
Nozin in Preventing Respiratory Viral Infections in Patients Undergoing Stem Cell Transplant, PREV-NOSE STUDY prevention 1 suspended NCT04054154
An Investigational Device (Millar Mikro-Tip Catheter) and Imaging Scan (Shear Wave Elastography) in Measuring Tumor Pressure and Stiffness in Patients With Solid Tumors Undergoing Ultrasound-Guided Biopsy No drug interventions device_feasibility Not Available active_not_recruiting NCT03023202
UWCCC Molecular Tumor Board Registry No drug interventions Not Available Not Available recruiting NCT03604315
Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF No drug interventions treatment 1 recruiting NCT01552356
Pazopanib Hydrochloride in Treating Patients With Advanced or Refractory Solid Tumors treatment 1 active_not_recruiting NCT02517034
Geriatric Assessment in Predicting Chemotherapy Toxicity and Vulnerabilities in Older Patients With Cancer No drug interventions supportive_care Not Available active_not_recruiting NCT02897375
Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors treatment 1 completed NCT03775616
Financial Navigation Program Intervention in Supporting Patients With Solid Tumors and Their Caregivers No drug interventions supportive_care Not Available completed NCT02650635
TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors treatment 1 terminated NCT02646319
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations treatment 0 completed NCT02540876
Ilorasertib in Treating Patients With CDKN2A-deficient Advanced or Metastatic Solid Cancers That Cannot Be Removed by Surgery treatment 1 completed NCT02360215
Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases supportive_care 3 completed NCT01907802
Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction treatment 1 terminated NCT01538095
Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System Tumors treatment 1 completed NCT00892736
Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy treatment 1 completed NCT00503854
Fatigue and Symptom Burden in Low-Risk Cancer Patients Undergoing Treatment for Febrile Neutropenia No drug interventions Not Available Not Available completed NCT00085553
Tipifarnib and Erlotinib Hydrochloride in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT01543282
Endoscopic Ultrasonography (EUS) Guided Fine Needle Aspiration Using Free Stylet 22g and 25 g Needles No drug interventions diagnostic Not Available completed NCT04420884
A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors treatment 1 / 2 recruiting NCT03833700
A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC) No drug interventions treatment 1 active_not_recruiting NCT04078295
A Study of E7389 Liposomal Formulation (E7389-LF) Plus Nivolumab in Participants With Solid Tumor treatment 1 / 2 active_not_recruiting NCT04407676
Improving Informed Consent for Early Phase Anti-Cancer Trials No drug interventions supportive_care Not Available recruiting NCT03364049
Study of MK-7162 in Combination With Pembrolizumab (MK-3475) in Adult Participants With Advanced Solid Tumors (MK-7162-002) treatment 1 completed NCT02896049
Celsius TCS Hyperthermia System PMCF Trial No drug interventions Not Available Not Available withdrawn NCT02791334
A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors treatment 1 active_not_recruiting NCT05219734
MRD Assay Evaluates Recurrence and Response Via a Tumor Informed Assessment No drug interventions Not Available Not Available active_not_recruiting NCT01848834
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-012/KEYNOTE-012) treatment 1 completed NCT04672434
Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies No drug interventions treatment 1 active_not_recruiting NCT01773434
A Phase 1 Study of MORAb-004 in Patients With Solid Tumor (Study: MORAb-004-J081-103) treatment 1 completed NCT03642834
Study of ICP-105 in Solid Tumors Patients No drug interventions treatment 1 completed NCT04306224
A Study of IMC-002 in Subjects With Metastatic or Locally Advanced Solid Tumors and Relapsed or Refractory Lymphomas No drug interventions treatment 1 completed NCT06028724
A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN) No drug interventions Not Available Not Available recruiting NCT06578624
Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 not_yet_recruiting NCT05708924
MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer treatment 1 suspended NCT05858424
Impact of a Multidisciplinary End-of-treatment Day Hospital on the Quality of Life of Adolescents and Young Adults With Cancer No drug interventions supportive_care Not Available recruiting NCT05702424
Evaluation of IGM-7354 in Adults With Relapsed and/or Refractory Cancer No drug interventions treatment 1 completed NCT05989724
A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT03297424
A Study of PLX2853 in Advanced Malignancies. No drug interventions treatment 1 completed NCT05269316
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT03654716
Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer treatment 1 completed NCT04348916
Study of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid Tumors treatment 1 terminated NCT05786716
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Teenage/Young Adult and Paediatric Patients With Cancers With HER2 Amplification or Activating Mutations treatment 2 / 3 recruiting NCT05940116
A Phase I Clinical Study of HS-20117 in Participants With Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT02494596
A Phase Ib, Open-label, Multicenter Study of the Safety and PK of the Combination of rhuMAb2c4 (Omnitarg), a Recombinant Humanized Antibody to HER2, and Capecitabine (Xeloda) in Patients With Advanced Solid Tumors treatment 1 completed NCT05580796
KSH01-R02-101 Solid Tumors No drug interventions treatment 0 recruiting NCT05940896
RC48-ADC Combined With Radiotherapy in the Treatment of Locally Advanced Solid Tumors With HER2 Expression treatment 1 recruiting NCT03286296
LZM009 to Treat Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT02920996
Merestinib In Non-Small Cell Lung Cancer And Solid Tumors treatment 2 terminated NCT01359696
A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma treatment 1 completed NCT02289196
Safety Study of Vx006 Vaccine in Solid Tumor Patients No drug interventions treatment 1 completed NCT05525858
KPMNG Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II Not Available Not Available recruiting NCT06487858
A Study of BGB-R046 as Monotherapy and in Combination With Tislelizumab in Solid Tumors treatment 1 recruiting NCT04826458
Clinical Study Comparing Different Strategies to Increase Adherence to Oral Therapies in Oncohematology No drug interventions health_services_research Not Available unknown_status NCT01099358
Study in Advanced Solid Tumors other 2 completed NCT05103358
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) treatment 2 active_not_recruiting NCT02355535
Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1 treatment 1 completed NCT02320435
A Safety and Efficacy Extension Study of Pertuzumab in Patients With Solid Tumors Previously Enrolled in a Hoffmann-La Roche-Sponsored Pertuzumab Clinical Trial treatment 3 active_not_recruiting NCT04586335
Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors. treatment 1 terminated NCT06403735
A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT01388335
A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin other 1 completed NCT05175235
Nivolumab and Pembrolizumab Dose Optimisation in Solid Tumours With CURATE.AI Platform and Sequential ctDNA Measurements treatment 1 / 2 recruiting NCT05807035
Autologous Tumour Vaccine Trial No drug interventions treatment 1 recruiting NCT04927663
11C-YJH08 PET Imaging for Detection of Glucocorticoid Receptor Expression No drug interventions diagnostic 1 recruiting NCT05190263
Quality Assurance on Anemia Management in Patients With Solid Tumors and Malignant Lymphoma No drug interventions Not Available Not Available completed NCT04200963
A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma treatment 1 completed NCT03647163
Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid Tumors treatment 1 / 2 recruiting NCT01929486
Phase Ia/Ib Multicenter Trial of Mogamulizumab for Advanced or Recurrent Cancer. treatment 1 unknown_status NCT02474186
Phase II Study for Solid Metastatic Tumors treatment 2 completed NCT05369286
A Study to Evaluate the Safety and Efficacy of Max-40279 and Toripalimab in Patients With Advanced Solid Tumors treatment 1 unknown_status NCT05380986
Camrelizumab Combined With Apatinib Mesylate treatment Not Available recruiting NCT03471286
A Window of Opportunity Study to Investigate Mechanisms of Actions of Novel Therapeutic Agents in Patients With Resectable Solid Tumor Malignancies treatment 1 terminated NCT05722886
DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol treatment 2 / 3 recruiting NCT04570839
COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors. treatment 1 / 2 completed NCT05934539
ALG.APV-527 First-in-human Study No drug interventions treatment 1 / 2 recruiting NCT02273739
Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation treatment 1 / 2 completed NCT03588039
Study of Oraxol and Pembrolizumab in Subjects With Advanced Solid Tumors treatment 1 terminated NCT03810339
Toripalimab as Monotherapy in Participants With POLE or POLD-1 Mutated and Non-MSI-H Advanced Solid Tumors treatment 2 recruiting NCT05785039
A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Locally Advanced or Metastatic Urinary System Tumors No drug interventions treatment 2 recruiting NCT04683939
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors treatment 1 / 2 terminated NCT03511222
Vorolanib (X-82) Combined With Checkpoint Inhibitors in Patients With Solid Tumors treatment 1 terminated NCT04886622
A Study of DT2216 in Relapsed/Refractory Malignancies treatment 1 completed NCT06086522
Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT01468922
Pazopanib and ARQ 197 for Advanced Solid Tumors treatment 1 completed NCT05093322
A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors treatment 1 / 2 completed NCT03866525
OH2 Oncolytic Viral Therapy in Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT02093325
A Study to Assess the Efficacy and Safety of Eltrombopag as a Rescue of Isolated Chemotherapy-induced Thrombocytopenia treatment 3 unknown_status NCT04122625
Study to Assess Safety and Efficacy of the Second Mitochondrial-derived Activator of Caspases (SMAC) Mimetic Debio 1143 treatment 1 / 2 completed NCT03815630
A Study of PD1 Combined With Dc-cik in the Treatment of Solid Tumors No drug interventions health_services_research 0 unknown_status NCT04469530
Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors treatment 2 recruiting NCT01804530
Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT05205330
CR6086/AGEN2034 Combination in Stage IV pMMR - MSS CRC, and Other Metastatic GI Cancers treatment 1 / 2 recruiting NCT06245330
A Phase I/II Study of AST-001 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT06337630
A Study on Tuvusertib (Oral ATR Inhibitor) in Combination With PLX038 (Topo1 Inhibitor) in Patients With Advanced Solid Tumors treatment 1 not_yet_recruiting NCT02393248
Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) treatment 1 / 2 terminated NCT03834948
AO-176 in Multiple Solid Tumor Malignancies treatment 1 / 2 completed NCT05717348
A Study of ES014 in Patients With Locally Advanced or Metastatic Solid Tumours No drug interventions treatment 1 recruiting NCT05391048
An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fed Condition other 1 unknown_status NCT04013048
Study to Evaluate the Mass Balance and Biotransformation of [14C]-Fluzoparib in Chinese Patients With Solid Tumor other 1 completed NCT04366648
Safety, Tolerability and Pharmacokinetics of Injectable PEG-Irinotecan (JK-1201I) in Patients with Malignant Solid Tumor No drug interventions treatment 1 completed NCT00982657
A Trial Of CVX-060, An Anti-Angiogenic COVX-Body, In Combination With Sunitinib In Patients With Advanced Renal Cell Carcinoma treatment 2 terminated NCT04101357
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411 treatment 1 / 2 terminated NCT04422457
Specific Molecular Imaging of DX600 Labeled by PET Radionuclide Targeting ACE2 in Patients No drug interventions diagnostic Not Available completed NCT04319757
ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors treatment 1 recruiting NCT05718557
Study of PYX-106 in Solid Tumors No drug interventions treatment 1 recruiting NCT01141257
Study of Angiocal® in Patients With Solid Tumors, Investigating Safety, Tolerability, Blood Concentration of Study Drug No drug interventions treatment 1 completed NCT01184326
Expanded Phase I Pazopanib and Everolimus in Advanced Solid Tumors and Previously Treated Advanced Urothelial Cancer treatment 1 completed NCT04982926
A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer No drug interventions treatment 1 active_not_recruiting NCT06425926
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT06094426
Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors No drug interventions treatment 0 recruiting NCT06515626
Genetically Modified T Cells Treating Malignant Tumors No drug interventions treatment 0 recruiting NCT05775666
UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT04198766
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) treatment 1 / 2 recruiting NCT01072266
A Dose-escalation Study in Subjects With Advanced Malignancies No drug interventions treatment 1 completed NCT05455866
Central Venous Catheter-related Complications in Patients Under Anticancer Treatment No drug interventions Not Available Not Available unknown_status NCT03053466
APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors treatment 1 completed NCT05735366
A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT02793466
Durvalumab in Pediatric and Adolescent Patients treatment 1 completed NCT03842865
Expanded Access of Vigil in Solid Tumors No drug interventions Not Available Not Available temporarily_not_available NCT01337765
Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients treatment 1 completed NCT05181865
Phase 1/2a Study to Evaluate FL-301 in Patients With Advanced Solid Tumors treatment 1 / 2 withdrawn NCT04351165
BA Study of IMP4297 (20mg vs 10mg) in Healthy Male Subjects other 1 completed NCT03710265
SHR-1701 in Metastatic or Locally Advanced Solid Tumors treatment 1 unknown_status NCT05859074
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer treatment 1 active_not_recruiting NCT02627274
A Study Evaluating Safety, Pharmacokinetics, and Therapeutic Activity of RO6874281 as a Single Agent (Part A) or in Combination With Trastuzumab or Cetuximab (Part B or C) treatment 1 completed NCT05192174
Study of NIB101 in Participants With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05566574
A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor Cancer treatment 1 / 2 recruiting NCT06005974
A Study of REC-4881 in Participants With Cancers Which Have an AXIN1 or APC Mutation No drug interventions treatment 2 recruiting NCT03834220
Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial) No drug interventions treatment 2 terminated NCT04455620
BNT151 as a Monotherapy and in Combination With Other Anti-cancer Agents in Patients With Solid Tumors No drug interventions treatment 1 / 2 terminated NCT03454620
A Study to Assess Safety, Efficacy, Immunogenicity, PK of GC1118 With Combination Chemotherapy treatment 1 / 2 completed NCT05412420
Artificial Intelligence to Search for Abnormalities in Ambulatory Cancer Patients No drug interventions prevention Not Available completed NCT03940820
Clinical Research of ROBO1 Specific CAR-NK Cells on Patients With Solid Tumors treatment 1 / 2 unknown_status NCT05383482
Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1 treatment 1 / 2 recruiting NCT03815682
RPTR-147 in Patients With Selected Solid Tumors and Lymphomas treatment 1 terminated NCT03560882
A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies treatment 1 active_not_recruiting NCT03865082
Study of Tilsotolimod in Combination With Nivolumab and Ipilimumab for the Treatment of Solid Tumors (ILLUMINATE-206) treatment 2 active_not_recruiting NCT02446431
Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence prevention 0 recruiting NCT05736731
A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Subjects With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression No drug interventions treatment 1 / 2 recruiting NCT04185831
A MolEcularly Guided Anti-Cancer Drug Off-Label Trial treatment 2 active_not_recruiting NCT05039931
A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 withdrawn NCT01017731
Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes Not Available 2 completed NCT01383473
Concurrent School Attendance And Cancer Therapy: The Experiences of 6-12 Year Old Pediatric Oncology Patients No drug interventions Not Available Not Available completed NCT03087227
Shared Health Information System for Febrile Neutropenia No drug interventions health_services_research Not Available completed NCT04205227
ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors treatment 1 / 2 active_not_recruiting NCT00898027
Effect of Epidermal Growth Factor Receptor Inhibitors on Magnesium Homeostasis in Patients With Cancer No drug interventions Not Available Not Available terminated NCT04258527
Phase 1 Study of Pemigatinib in Patients With Advanced Malignancies With FGF/FGFR Alterations treatment 1 completed NCT03739827
Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors No drug interventions Not Available Not Available recruiting NCT04706676
Integrative Neuromuscular Training in Adolescents and Children Treated for Cancer No drug interventions prevention Not Available recruiting NCT04276376
Efficacy and Safety of the Combination of Rucaparib (PARP Inhibitor) and Atezolizumab (Anti-PD-L1 Antibody) in Patients With DNA Repair-deficient or Platinum-sensitive Solid Tumors treatment 2 suspended NCT05707676
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of LB4330 in Patients With Advanced Solid Tumors（MEETCD8-001） No drug interventions treatment 1 recruiting NCT06212076
Phase I/II Study of IPG1094 in Advanced Solid Tumors Patients No drug interventions treatment 1 / 2 not_yet_recruiting NCT06022276
Nimotuzumab for EGFR-amplified Advanced Pan Solid Tumors treatment Not Available recruiting NCT06106360
A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy No drug interventions Not Available Not Available recruiting NCT03960060
A Study of CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid Tumors No drug interventions treatment 1 unknown_status NCT03680560
Study of ACTR T Cell Product in Combination With Trastuzumab in Subjects With HER2-Positive Advanced Solid Tumor Cancers treatment 1 terminated NCT03770494
A Study of LY3405105 in Participants With Advanced Cancer No drug interventions treatment 1 terminated NCT04433494
A Study of TY-302 in Patients With Advanced Solid Tumors treatment 1 unknown_status NCT06429891
Research on Early Diagnosis and Clinical Transformation of Nuclide Probe Based on Bioorthogonal-gastric Cancer Mucin Target Visualization diagnostic Not Available recruiting NCT05580991
Intratumoral CAN1012(Selective TLR7 Agonist) in Subjects With Solid Tumors No drug interventions treatment 1 recruiting NCT03718091
M6620 (VX-970) in Selected Solid Tumors treatment 2 completed NCT05954091
OH2 Administered by Intratumoral Injection treatment 1 not_yet_recruiting NCT05522491
Olaparib in the Treatment of BRCA1/2 Unmutated and BRCA1 Promoter Methylated Recurrent and Metastatic Triple-negative Breast Cancer treatment 2 unknown_status NCT05423262
A Study of TRK-950 in Patients With Advanced Solid Tumors treatment 1 active_not_recruiting NCT00624962
Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors No drug interventions supportive_care Not Available withdrawn NCT02412462
Phase I Dose Escalation Study of AB-16B5 in Subjects With an Advanced Solid Malignancy treatment 1 completed NCT04706962
TH1902 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05642780
SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors treatment 2 recruiting NCT04802980
A Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor treatment 1 unknown_status NCT04775680
Study of ADG106 In Combination With PD-1 Antibody In Advanced or Metastatic Solid Tumors and/or Non Hodgkin Lymphoma No drug interventions treatment 1 / 2 terminated NCT02932280
Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment treatment 1 / 2 active_not_recruiting NCT01248429
Prevalence of Creatinine Phosphokinase Increase in Patients With Solid Tumors Treated by Inhibitors of Tyrosine Kinases No drug interventions Not Available Not Available completed NCT04905329
A Multicenter Prospective Post-registration Study of Empegfilgrastim to Evaluate Safety and Efficacy in Special Cancer Populations Not Available Not Available unknown_status NCT05009329
A Study of JAB-21822 in Adult Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation in China treatment 1 / 2 active_not_recruiting NCT03823989
Intravenously Administered Liposomal PROMITIL in Combination With External Beam Radiotherapy in Cancer Patients treatment 1 completed NCT02963389
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim in Pediatric Solid Tumor/Lymphoma Patients No drug interventions prevention 1 completed NCT04143789
Evaluation of AP-002 in Patients With Solid Tumors treatment 1 / 2 unknown_status NCT04047589
Assessing Exercise Behavior and Preferences Among Patients and Oncologists No drug interventions Not Available Not Available completed NCT05578092
A Phase 1/2 Study of MRTX0902 in Solid Tumors With Mutations in the KRAS MAPK Pathway treatment 1 / 2 recruiting NCT04553692
Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants With Relapsed, Refractory, or Newly Diagnosed Cancers treatment 1 active_not_recruiting NCT04970992
A Pharmacokinetic and Pharmacodynamic Study of DZ-002 in Patients With Advanced Solid Malignancies or Lymphoma No drug interventions treatment 1 recruiting NCT05385692
A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors or Other Solid Tumors No drug interventions treatment 1 recruiting NCT03249792
Study of MK-2118 Administered as Intratumoral Injection as Monotherapy and in Combination With Pembrolizumab (MK-3475) or by Subcutaneous Injection in Combination With Pembrolizumab in the Treatment of Adults With Advanced/Metastatic Solid Tumors or Lymphomas (MK-2118-001) treatment 1 terminated NCT02255292
A Study: Pure CBD as Single-agent for Solid Tumor. treatment 2 unknown_status NCT03264092
Comparison of Three Tissue Acquiring Techniques During EUS Guided Biopsies of Solid Tumors. No drug interventions diagnostic Not Available terminated NCT06410092
Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of FTL001 No drug interventions treatment 1 recruiting NCT05770544
DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Teenage/Young Adults and Paediatric Patients With ROS1 Gene Fusion-positive Cancers. treatment 2 / 3 recruiting NCT04513444
Interest of Medical Hypnosis in Anxious Patients Treated by Radiotherapy No drug interventions supportive_care 2 recruiting NCT01364844
Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors No drug interventions treatment 1 completed NCT03130140
MOSE to Improve the Diagnostic Accuracy During EUS-guided FNA Using a 19-gauge Needle for Solid Lesions No drug interventions diagnostic Not Available completed NCT06116240
A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors treatment 1 active_not_recruiting NCT05544240
Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT06117540
A Study of WX390 in Patients With Advanced Solid Tumors No drug interventions treatment 2 recruiting NCT01596140
Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer treatment 1 completed NCT03894540
Dose Escalation and Dose Expansion Study of IPN60090 in Patients With Advanced Solid Tumours treatment 1 terminated NCT04862767
TASO-001 in Combination With Recombinant Interleukin-2(Aldesleukin) in Advanced or Metastatic Solid Tumor treatment 1 completed NCT03600467
Activity of Seviteronel in Patients With Androgen Receptor (AR)-Positive Glioblastoma treatment 2 terminated NCT02030067
Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies treatment 1 / 2 completed NCT03809767
A Study of CS1003 in Subjects With Advanced Solid Tumors or Lymphomas treatment 1 completed NCT04074967
Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab treatment 1 / 2 active_not_recruiting NCT03977467
Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 Inhibitor treatment 2 completed NCT06541301
PICC-ports Versus Chest - Ports for Long Term Chemotherapy Deliverance in Oncology Patients No drug interventions other Not Available not_yet_recruiting NCT01401504
Study of an Investigational Drug, ASP3026, in Patients With Solid Tumors treatment 1 completed NCT04832204
Apatinib Combined With SHR-1210 as Second-line Treatment in Solid Tumors With Only Liver Metastases treatment 2 unknown_status NCT03943004
Trial of DFP-14927 in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT03166904
Phase II Trial of AZD2014 in RICTOR Amplified Solid Cancer Patients Refractory to Standard Chemotherapy treatment 2 withdrawn NCT00717704
Solid Tumors Using Ixabepilone and Dasatinib treatment 1 completed NCT02541604
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Preliminary Efficacy of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Pediatric and Young Adult Participants With Solid Tumors treatment 1 / 2 terminated NCT04165772
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors treatment 2 recruiting NCT02737072
A Study of LY2510924 and Durvalumab in Participants With Solid Tumors treatment 1 terminated NCT03006172
To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer treatment 1 active_not_recruiting NCT03207672
Study of E7389 Liposomal Formulation in Participants With Solid Tumor treatment 1 active_not_recruiting NCT04794972
A Study of GNC-039, a Tetra-specific Antibody, in Participants With Relapsed/Refractory or Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT02937272
A Study of LY3200882 in Participants With Solid Tumors treatment 1 active_not_recruiting NCT05360368
HLX07(Anti-EGFR mAb) in Patients With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 unknown_status NCT00820768
A Trial of ABI-010 & ABI-007 in Patients With Advanced Non-Hematologic Malignancies treatment 1 withdrawn NCT04984668
A Phase Ib/II Study of GT90001 Combined With KN046 in Solid Tumors treatment 1 / 2 recruiting NCT05522868
SB17170 Phase 1 Clinical Trial in Solid Tumors No drug interventions treatment 1 recruiting NCT00499668
Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer supportive_care Not Available withdrawn NCT05284968
RD07 Cell Injection in the Treatment of Patients With Advanced Claudin18.2 Positive Solid Tumors No drug interventions treatment 0 not_yet_recruiting NCT06188468
ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Solid Tumors No drug interventions diagnostic Not Available recruiting NCT02963168
A DRF Study to Evaluate Safety, Tolerability, PK, and Activity of Oradoxel Monotherapy in Subjects w Adv. Malignancies treatment 1 unknown_status NCT02536469
HuMax-IL8 (Interleukin8) in Patients With Advanced Malignant Solid Tumors No drug interventions treatment 1 completed NCT00721669
A Phase I Dose-Escalation Study of IMGN388 in Patients With Solid Tumors No drug interventions treatment 1 completed NCT06015269
Exploratory Study on Baize DC Injection in Preventing Recurrence and Metastasis After Radical Tumor Surgery No drug interventions prevention 1 recruiting NCT03489369
Sym022 (Anti-LAG-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas No drug interventions treatment 1 completed NCT04184869
Extension Study for Patients Who Had Not Met Criteria for Discontinuation in Previous Sponsored Belinostat Trials treatment 1 completed NCT04316169
Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer treatment 1 withdrawn NCT04260269
Feasibility of Switching Fluoropyrimidine Due to Cardiotoxicity Study Not Available Not Available enrolling_by_invitation NCT02471846
A Study of GDC-0919 and Atezolizumab Combination Treatment in Participants With Locally Advanced or Metastatic Solid Tumors treatment 1 completed NCT00781846
Trial of Deforolimus in Combination With Bevacizumab for Patients With Advanced Cancers (8669-010)(COMPLETED) treatment 1 completed NCT04928612
A Study of CBP-1018 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04796012
VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors treatment 1 / 2 recruiting NCT03311412
Sym021 Monotherapy, in Combination With Sym022 or Sym023, and in Combination With Both Sym022 and Sym023 in Patients With Advanced Solid Tumor Malignancies or Lymphomas No drug interventions treatment 1 completed NCT01234012
Study of IMF-001 in Patients With Malignancies Expressing NY-ESO-1 No drug interventions treatment 1 completed NCT02840110
Long-Term Follow-Up Study of Subjects Treated With ACTR T Cell Product No drug interventions Not Available Not Available terminated NCT02876510
ACTolog in Patients With Solid Cancers treatment 1 completed NCT05416710
Universal Germline Testing in the Community No drug interventions Not Available Not Available recruiting NCT02274610
Pharmacokinetic Study of Docetaxel-PNP and Taxotere to Treat Patient With Advanced Solid Cancer treatment 1 completed NCT01239381
Individualized Stereotactic Body Radiotherapy of Liver Metastases No drug interventions treatment Not Available completed NCT02049281
A Study of Vintafolide (MK-8109) in Participants With Advanced Solid Tumor (MK-8109-011) treatment 1 terminated NCT04346381
Study to Evaluate the Efficacy and Safety of Camrelizumab and Famitinib in Patients With Advanced Solid Tumor treatment 2 completed NCT05097781
Local Radiotherapy in Combination With Immunotherapy in Advanced Solid Tumors Patients No drug interventions treatment 2 unknown_status NCT04280081
A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation treatment 2 active_not_recruiting NCT02730481
A Study to Evaluate the Safety, Tolerability, MTD, PK, and Activity of Oraxol in Subjects w Adv. Malignancies treatment 1 completed NCT05821595
JYB1907 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT04344795
Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors treatment 1 active_not_recruiting NCT05246995
A Phase I Study of IBI325 in Patients With Advanced Solid Tumor treatment 1 unknown_status NCT03928314
Study of ORIC-101 in Combination With Anticancer Therapy treatment 1 terminated NCT03934814
Study of TJ011133 in Participants With Relapsed/Refractory Advanced Solid Tumors and Lymphoma treatment 1 completed NCT05284214
Sargramostim With Ipilimumab Containing Therapy in Patients With Solid Tumors treatment 2 withdrawn NCT04617314
A Study of RC108-ADC in Subjects With Advanced Malignant Solid Tumors No drug interventions treatment 1 recruiting NCT05162755
S095029 as Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies Followed by an Expansion Part With Triple Combinations in Patients With Metastatic Gastric or Colorectal Cancers treatment 1 active_not_recruiting NCT05023655
Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation treatment 2 recruiting NCT00737555
A Study of the Safety and Tolerability of the Addition of CHR-2797 to Paclitaxel in Patients With Advanced or Refractory Tumours treatment 1 completed NCT06310655
Online Proton Adaptive Radiotherapy No drug interventions treatment Not Available recruiting NCT06171750
Phase I Study of ANK-101 in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT01134250
Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour Patients treatment 1 / 2 completed NCT03973450
Epidemiology of Pituitary Tumours: Prevalence of Associated Neoplasia No drug interventions Not Available Not Available unknown_status NCT03636750
A Study of Injection HB002.1T in Subjects With Solid Tumor No drug interventions treatment 1 completed NCT02278250
First in Human Study of M4344 in Participants With Advanced Solid Tumors treatment 1 completed NCT01585623
Drug Interaction Study of SAR302503 in Patients With Solid Tumor treatment 1 completed NCT03544723
Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors. treatment 2 unknown_status NCT02476123
Study of Combination Therapy With Mogamulizumab (KW-0761) and Nivolumab (ONO-4538/BMS-936558) in Subjects With Advanced Solid Tumors treatment 1 completed NCT04475523
Phase 1 Study of CI-8993 Anti-VISTA Antibody in Patients With Advanced Solid Tumor Malignancies No drug interventions treatment 1 completed NCT06239623
ERK Inhibitor JSI-1187 in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04419623
A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer treatment 1 completed NCT06234423
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT03712423
PET Study With [89Zr]-Df-CriPec® Docetaxel treatment 1 completed NCT04931823
Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT04403308
ONO-7913 Phase I Study (ONO-7913) No drug interventions treatment 1 completed NCT02640508
Eribulin and Lenvatinib in Advanced Solid Tumors treatment 2 completed NCT06469008
A Study of BL-B16D1 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors No drug interventions treatment 1 recruiting NCT05046808
Pharmacokinetics Study of Famitinib Malate Capsules in Healthy Subjects No drug interventions basic_science 1 completed NCT01425008
Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma treatment 1 completed NCT04541108
Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies basic_science 0 recruiting NCT03707808
Intratumoral Injection of Autologous CD1c (BDCA-1)+ myDC, Avelumab, and Ipilimumab Plus Systemic Nivolumab treatment 1 completed NCT05748938
A Study of RD14-01 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT02285738
Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis supportive_care 0 completed NCT02575638
Safety Study of Camptothecin-20-O-Propionate Hydrate (CZ48) No drug interventions basic_science 1 unknown_status NCT05381038
Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AI treatment 1 / 2 not_yet_recruiting NCT02846038
Understanding Communication in Healthcare to Achieve Trust (U-CHAT) No drug interventions Not Available Not Available completed NCT04096638
Safety and Efficacy of SB 11285 Alone and in Combination With Atezolizumab in Patients With Advanced Solid Tumors treatment 1 active_not_recruiting NCT00786838
A Study to Assess the Potential Effects of a Single-Dose Administration of Trabectedin on the QT Intervals of the Electrocardiogram treatment 2 completed NCT01967043
A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oraxol in Subjects With Advanced Malignancies No drug interventions treatment 1 completed NCT02423343
A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma treatment 1 / 2 completed NCT03489343
Sym023 (Anti-TIM-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas No drug interventions treatment 1 completed NCT05981703
A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors treatment 1 recruiting NCT03164603
NLG802 Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Advanced Solid Tumors No drug interventions treatment 1 completed NCT02950103
Efficacy and Safety of Synthetic Phosphoethanolamine in Solid Tumor Patients No drug interventions treatment 2 terminated NCT00701103
Dose Escalation Trial of Dalotuzumab (MK-0646) in Advanced Solid Tumors and Multiple Myeloma (MK-0646-001) treatment 1 completed NCT03637803
Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors treatment 1 / 2 terminated NCT02548390
Study of Intravenous RXDX-107 in Patients With Solid Tumors No drug interventions treatment 1 terminated NCT03592264
A Phase I/II Study of OBI-3424 in Subjects With Advanced Solid Tumors treatment 1 / 2 terminated NCT05787964
Immunity to Infection in Healthy Participants and Participants With Cancer No drug interventions Not Available Not Available active_not_recruiting NCT05626764
QUALITOP - Monitoring Multidimensional Aspects of QUAlity of Life After Cancer ImmunoTherapy, an Open Smart Digital Platform for Personalized Prevention and Patient Management No drug interventions Not Available Not Available recruiting NCT06493864
A Study of BL-B16D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT06105021
Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor No drug interventions treatment 1 / 2 recruiting NCT04678921
Study of TJ210001 Administered in Subjects With Relapsed or Refractory Advanced Solid Tumors No drug interventions treatment 1 completed NCT06368921
A Study of Recombinant Oncolytic Virus M1(VRT106) in Patients With Solid Tumors No drug interventions treatment 1 recruiting NCT06014502
Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04601402
GEN-001 (Live Biotherapeutic Product) and Avelumab Combination Study for Patients With Solid Tumors Who Have Progressed on Anti-PD-(L)1 Therapy treatment 1 completed NCT02466802
Study of Regorafenib and Sildenafil for Advanced Solid Tumors treatment 1 completed NCT00333502
Study of CRLX101 (NLG207) in the Treatment of Advanced Solid Tumors treatment 1 / 2 completed NCT03815084
A Study of PD1 Combined With DC-NK Cell in the Treatment of Solid Tumors health_services_research 0 unknown_status NCT03027284
A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic Cancer treatment 1 completed NCT05282784
Hyperthermia With Flexible Electrode-typed 2-MHz Device During Radiotherapy for Solid Tumors No drug interventions treatment Not Available unknown_status NCT05585684
Liquid Biopsy-informed Precision Oncology Study to Evaluate Utility of Plasma Genomic Profiling for Therapy Selection No drug interventions Not Available Not Available recruiting NCT04522284
PRECISE CURATE.AI Pilot Clinical Trial treatment 1 / 2 recruiting NCT05250284
The Intersection of Oncology Care and Worker Well-Being No drug interventions Not Available Not Available active_not_recruiting NCT00808184
Pharmacokinetic Study of CPT-11, Raltegravir and Midazolam With Characterisation of UGT1A1 Genotype treatment 4 completed NCT03774979
SHR-1701 in Subjects With Metastatic or Locally Advanced Solid Tumors treatment 1 unknown_status NCT04508179
A Phase 1 SAD and MAD Study of the Safety, Tolerability and PK of 7HP349 in Normal Healthy Male Subjects treatment 1 completed NCT03602079
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene No drug interventions treatment 1 / 2 completed NCT00467779
Study of Cobimetinib in Participants With Solid Tumors treatment 1 completed NCT05938296
oHSV2-PD-L1/CD3-BsAb Administered Via Intratumoral Injection No drug interventions treatment 1 recruiting NCT06305247
A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours No drug interventions treatment 1 / 2 recruiting NCT03975387
Study of ASTX295 in Patients With Solid Tumors With Wild-Type p53 No drug interventions treatment 1 / 2 active_not_recruiting NCT04078152
Durvalumab Long-Term Safety and Efficacy Study treatment 4 active_not_recruiting NCT04937153
GEN1046 Safety and PK in Subjects With Advanced Solid Malignancies treatment 1 active_not_recruiting NCT06576037
Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin treatment 1 not_yet_recruiting NCT03493945
Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1) treatment 1 / 2 active_not_recruiting NCT03570619
Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations treatment 2 completed NCT04084067
Indocyanine Green (ICG) Guided Tumor Resection diagnostic 1 recruiting NCT04381806
Phase I Study in Advanced Malignancies With 5-ALA treatment 1 recruiting NCT04537715
Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels treatment 1 completed NCT05086692
A Beta-only IL-2 ImmunoTherapY Study treatment 1 / 2 recruiting NCT05088070
Clinical Study of SPH3348 Tablets, a C-Met Inhibitor, in Patients with Advanced Solid Tumors No drug interventions treatment 1 completed NCT05128487
A Study of NDI 1150-101 in Patients With Solid Tumors treatment 1 / 2 recruiting NCT05199272
A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies No drug interventions treatment 1 / 2 active_not_recruiting NCT05382559
A Study of ASP3082 in Adults With Previously Treated Solid Tumors treatment 1 recruiting NCT06579469
Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy No drug interventions Not Available Not Available not_yet_recruiting NCT06299761
Study of the RNR Inhibitor BBI-825 in Subjects With Tumors With Resistance Gene Amplifications No drug interventions treatment 1 recruiting NCT06349837
Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors treatment 1 recruiting NCT06384807
A Phase 1/2 Study of PBI-410 in Advanced Solid Tumors treatment 1 / 2 recruiting NCT06563375
Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid Tumors treatment 1 not_yet_recruiting NCT03016806
Umbilical Cord Blood Transplantation From Unrelated Donors treatment 1 recruiting NCT03340506
Dabrafenib and/or Trametinib Rollover Study treatment 4 recruiting NCT03667170
KN035 for dMMR/MSI-H Advanced Solid Tumors treatment 2 recruiting NCT04050709
QUILT-3.064: PD-L1 t-haNK In Subjects With Locally Advanced Or Metastatic Solid Cancers treatment 1 active_not_recruiting NCT04304066
Research for the Molecular Imaging of the PD-L1 Targeting Tracer No drug interventions diagnostic Not Available active_not_recruiting NCT04891198
ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors treatment 2 recruiting NCT05245500
Phase 1/2 Study of MRTX1719 in Solid Tumors With MTAP Deletion treatment 1 / 2 recruiting NCT05500508
Oral AMXT 1501 Dicaprate in Combination With IV DFMO treatment 1 / 2 suspended NCT05786924
A Study of BDTX-4933 in Patients With KRAS, BRAF and Select RAS/MAPK Mutation-Positive Cancers No drug interventions treatment 1 recruiting NCT05840224
Study of GS-4528 in Adults With Solid Tumors treatment 1 recruiting NCT05935098
A Study of BGB-A3055, Alone and in Combination With Tislelizumab in Participants With Selected Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT06171178
A Study of ASP1012 in Adults With Solid Tumors treatment 1 recruiting NCT06500052
A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid Tumors No drug interventions treatment 1 recruiting NCT06536257
Personalised Immunotherapy Platform No drug interventions Not Available Not Available recruiting NCT03658785
Immunotherapy for the Treatment of Advanced Solid Tumor treatment 1 / 2 recruiting NCT04552288
Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies treatment 2 active_not_recruiting NCT04939610
A Study of 177Lu-FAP-2286 in Advanced Solid Tumors (LuMIERE) treatment 1 / 2 recruiting NCT05119907
Study of Sacituzumab Govitecan in Patients With Solid Tumor treatment 2 recruiting NCT05159388
A Study of PRS-344/S095012 (PD-L1x4-1BB Bispecific Antibody-Anticalin Fusion) in Patients With Solid Tumors No drug interventions treatment 1 / 2 active_not_recruiting NCT05169437
Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors treatment 2 active_not_recruiting NCT05244551
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK061 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05507736
Feasibility and Safety of Acupuncture in the Prevention of Late Irinotecan-related Diarrhea in Pediatric Patients No drug interventions other Not Available completed NCT05989997
Phase I Clinical Trial of 68Ga-NOTA-SNA002 No drug interventions diagnostic 1 recruiting NCT06010342
A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients No drug interventions treatment 2 recruiting NCT06549946
Ixovex-1 Single Agent and Combination Therapy treatment 1 / 2 not_yet_recruiting NCT02909777
Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma treatment 1 active_not_recruiting NCT03611595
Cabozantinib in Combination With 13-cis-Retinoic Acid in Children With Relapsed or Refractory Solid Tumors treatment 1 recruiting NCT05266612
Phase I Study VG2025 as a Single Agent and in Combination Therapy With Nivolumab in Subjects With Advanced Malignant Solid Tumors treatment 1 recruiting NCT05627063
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK121-NX in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05720117
Study of PYX-201 in Solid Tumors treatment 1 recruiting NCT06452160
A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06475131
A Study of BL-B16D1 in Patients With Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT06503783
A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Negative Breast Cancer and Other Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT06537505
A Study of Microwave Ablation Combined With Immunotherapy ± Anti-angiogenic Drugs in the Treatment of Solid Tumors treatment 2 not_yet_recruiting NCT06526819
A Phase 1/2 Study of SMP-3124LP in Adults With Advanced Solid Tumors No drug interventions treatment 1 / 2 not_yet_recruiting NCT06528249
Safety, Tolerability and Preliminary Efficacy of Erythrocyte-αPD-1 Conjugate in Patients With Advanced Malignancies No drug interventions treatment 1 not_yet_recruiting NCT06531486
A Study of XS-02 Capsules in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 not_yet_recruiting NCT03396445
Study of Boserolimab (MK-5890) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Adults With Advanced Solid Tumors (MK-5890-001) treatment 1 active_not_recruiting NCT03872947
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors treatment 1 recruiting NCT05076552
A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of Oral TACH101 in Participants With Advanced or Metastatic Cancer No drug interventions treatment 1 active_not_recruiting NCT06132828
Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT06535009
Study of ONO-7914 Alone and in Combination With ONO-4538 in Patients With Solid Tumors treatment 1 recruiting NCT06258330
Study of AM003 in Patients With Locally Advanced and Metastatic Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT06524024
Clinical Study of Tumor Polypeptide DC-CTL in the Treatment of Solid Tumors No drug interventions treatment Not Available not_yet_recruiting NCT04305249
Safety and Preliminary Efficacy of ATG-017 Monotherapy or Combination Therapy With Nivolumab in Advanced Solid Tumors and Hematological Malignancies treatment 1 terminated NCT04393454
Study to Evaluate the Efficacy and Safety of Sirolimus in Subjects With Metastatic, Mismatch Repair Deficient Solid Tumors After Immunotherapy treatment 2 terminated NCT04787042
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067 treatment 1 / 2 active_not_recruiting NCT05338658
Study of PAT in Patients With Solid Tumor Cancers treatment 1 suspended NCT05645523
Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors diagnostic 0 recruiting NCT05678010
A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer No drug interventions treatment 1 recruiting NCT05707325
Safety, Tolerability and Preliminary Efficacy of Engineered Red Blood Cell in Patients With Advanced Malignancies No drug interventions treatment 0 recruiting NCT05985161
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors treatment 2 recruiting NCT06036836
Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010) treatment 2 recruiting NCT06308263
M1774 Human Mass Balance Study (DDRIVER Solid Tumors 303) treatment 1 recruiting NCT06375187
Engineering Tumor Infiltrating Lymphocytes Injection (GC203 TIL) for the Treatment of Advanced Malignant Solid Tumors No drug interventions treatment 1 recruiting NCT06512896
Clinical Study on Intraluminal Injection of FOLactis No drug interventions treatment Not Available recruiting NCT06504732
To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Gastric Cancer No drug interventions treatment 2 / 3 not_yet_recruiting NCT03641547
M6620 Plus Standard Treatment in Oesophageal and Other Cancer treatment 1 completed NCT03991832
Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors treatment 2 recruiting NCT04606472
A Study of SI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05159245
The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs treatment 2 recruiting NCT05470348
A Study of BL-B01D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors No drug interventions treatment 1 recruiting NCT05729399
Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Solid Tumors No drug interventions treatment 0 recruiting NCT05803018
A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies No drug interventions treatment 1 / 2 recruiting NCT05965856
A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid Tumors No drug interventions treatment 2 recruiting NCT06264921
A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT06336148
A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT01639950
Validating Pain Scales in Children and Young Adults No drug interventions Not Available Not Available completed NCT03229200
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib. treatment 4 enrolling_by_invitation NCT03247309
TCR-engineered T Cells in Solid Tumors (ACTengine IMA201-101) No drug interventions treatment 1 completed NCT04015609
Psychotherapy Intervention for Latinos With Advanced Cancer No drug interventions supportive_care Not Available recruiting NCT04641871
Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies treatment 1 completed NCT04794699
Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion treatment 1 recruiting NCT04952272
Intratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05228015
Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects With Advanced Solid Tumors treatment 1 active_not_recruiting NCT05403177
Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O) No drug interventions Not Available Not Available recruiting NCT05737706
Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation No drug interventions treatment 1 / 2 recruiting NCT05919264
FOG-001 in Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT06398418
R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT06465017
ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer No drug interventions diagnostic Not Available recruiting NCT05557045
A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815 No drug interventions treatment 1 recruiting NCT05672459
A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid Tumors treatment 1 / 2 recruiting NCT06160752
Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations No drug interventions treatment 1 recruiting NCT06468358
A Study to Evaluate LB1410 in Combination With LB4330 in Patients With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT06475300
A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors No drug interventions treatment 2 recruiting NCT06239298
A Study of ZG005 Combined With Donafenib in Patients With Advanced Solid Tumor treatment 1 / 2 recruiting NCT06234098
Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT06290388
Study of 23ME-01473 in Patients With Advanced Solid Malignancies No drug interventions treatment 1 / 2 recruiting NCT06456216
Performance Evaluation of Diagnostic Accuracy of PanTum Detect Test for Detection of Solid Tumours in Known Cancer Population and in Cancer Free Population. No drug interventions Not Available Not Available completed NCT02834052
Pembrolizumab + Poly-ICLC in MRP Colon Cancer treatment 1 / 2 completed NCT04731467
A Study of CM24 in Combination With Nivolumab in Adults With Advanced Solid Tumors treatment 1 / 2 active_not_recruiting NCT05323045
A First-in-human Dose-escalation and Expansion Study With the Antibody-drug Conjugate BYON3521 No drug interventions treatment 1 active_not_recruiting NCT06443307
Real-world Study to Evaluate the Efficacy and Safety of Liposome Irinotecan Not Available Not Available recruiting NCT06443710
Technetium [99mTc]-H7ND in Patients With Gastrointestinal Malignancies and Healthy Volunteers No drug interventions diagnostic 1 not_yet_recruiting NCT03307785
Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042 treatment 1 active_not_recruiting NCT04400383
Clinical Trial to Evaluate AB011 Injection in Patients With CLDN18.2-positive Advanced Solid Tumors No drug interventions treatment 1 completed NCT04503278
A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors No drug interventions treatment 1 recruiting NCT04516447
A Study of ZN-c3 in Patients With Ovarian Cancer treatment 1 recruiting NCT05584670
A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors treatment 1 / 2 recruiting NCT02332668
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051) treatment 1 / 2 recruiting NCT03238027
A Phase 1 Study to Investigate Axatilimab Alone or in Combination With Durvalumab in Patients With Solid Tumors treatment 1 completed NCT05262530
Safety and Preliminary Efficacy Trial of BNT142 in Patients With CLDN6-positive Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05301101
High Dose Re-Irradiation Utilizing Advanced Deformable Image Registration (DIR) and Individualized Organ At Risk (OAR) Dose Calculations With Organ Specific Toxicity Analysis No drug interventions treatment Not Available recruiting NCT05735080
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer No drug interventions treatment 1 / 2 recruiting NCT02608385
Study of PD1 Blockade by Pembrolizumab With Stereotactic Body Radiotherapy in Advanced Solid Tumors treatment 1 active_not_recruiting NCT05306509
Nurse-initiated Conversations for Early Integration of Palliative Care in Pediatric Oncology No drug interventions supportive_care Not Available recruiting NCT05346484
A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors treatment 1 recruiting NCT05653882
A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors treatment 1 recruiting NCT05826600
A Study of OMX-0407 in Patients With Previously Treated Solid Tumours That Can't be Removed Surgically No drug interventions treatment 1 / 2 recruiting NCT06046742
A Study of Intravenous M1-c6v1 for Locally Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT06416436
Dose-escalation Study of Ultra-high Dose Ablative Radiosurgery With Immunotherapy for Bulky Metastatic Cancer Patients treatment 1 not_yet_recruiting NCT02624388
Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) supportive_care 2 terminated NCT02663518
A Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid Tumors treatment 1 terminated NCT03839342
Binimetinib and Encorafenib for the Treatment of Advanced Solid Tumors With Non-V600E BRAF Mutations treatment 2 active_not_recruiting NCT04250597
Study of GNX102 in Patients With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT04710043
Dose Escalation Trial of BNT152+153 in Patients With Cancer No drug interventions treatment 1 recruiting NCT05002868
Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors No drug interventions treatment 1 completed NCT06401356
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib treatment 3 not_yet_recruiting NCT02041416
Technology to Assess Vulnerable Older Adults With Cancer and Their Caregivers No drug interventions Not Available Not Available active_not_recruiting NCT04800822
PF-07284892 in Participants With Advanced Solid Tumors treatment 1 active_not_recruiting NCT06364696
A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors No drug interventions treatment 1 recruiting NCT06394622
A Clinical Research About CD70-targeted CAR-NKT Cells Therapy Advanced Malignant Solid Tumors treatment 1 recruiting NCT00921336
Safety Study to Evaluate KW-2450 in Subjects With Advanced Solid Tumor treatment 1 completed NCT02705105
Study of Mogamulizumab + Nivolumab in Subjects w/Locally Advanced or Metastatic Solid Tumors treatment 1 / 2 completed NCT02867007
KHK2455 Alone and in Combination With Mogamulizumab in Subjects With Locally Advanced or Metastatic Solid Tumors treatment 1 completed NCT05173792
Study of AK119 in Subjects With Advanced Solid Tumors treatment 1 completed NCT06383598
PD-L1 Specific [68Ga]-Nb-1 Nanobody Probe for PET Imaging in Solid Tumors diagnostic Not Available recruiting NCT04059588
A Study Investigating the Safety and Tolerability of an Immune Treatment in Cancer Patients With Lesions to the Skin No drug interventions other 1 completed NCT05581719
A Phase 1/2a Study Evaluating Allocetra-OTS as Monotherapy or in Combination With Anti-PD-1 Therapy for the Treatment of Advanced Solid Tumor Malignancy treatment 1 / 2 terminated NCT06210815
A Study of HLX42 in Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT00736749
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies No drug interventions Not Available Not Available recruiting NCT03861156
D-0316 in Patients With EGFR Positive Non Small Cell Lung Cancer treatment 2 completed NCT04557306
Evaluationn of Tolerability and Safety of CBT101, an Autologous Natural Killer Cell, in Patients With Solid Cancer treatment 1 completed NCT04690699
LUMINOS-103: A Basket Trial Evaluating the Safety and Efficacy of Lerapolturev (PVSRIPO) and Lerapolturev in Combination With Anti-PD-1/L1 Checkpoint Inhibitors in Patients With Advanced Solid Tumors treatment 1 / 2 active_not_recruiting NCT05390827
Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol No drug interventions Not Available Not Available recruiting NCT05991349
A Study of IBI129 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT00479128
Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors treatment 1 active_not_recruiting NCT03829254
A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma treatment 1 / 2 recruiting NCT04666688
LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors treatment 1 / 2 recruiting NCT05176483
Study of XL092 in Combination With Immuno-Oncology Agents in Subjects With Solid Tumors treatment 1 recruiting NCT06342336
HS-IT101 Injection in the Treatment of Advanced Solid Tumors treatment 1 recruiting NCT06339541
The ACC Preclinical Research Platform for Precision Oncology No drug interventions Not Available Not Available recruiting NCT02806388
Individualized Molecular Profiling for Allocation to Clinical Trials (IMPACT) Project No drug interventions Not Available Not Available recruiting NCT03013218
A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01) treatment 1 active_not_recruiting NCT04537936
Psychotherapy Intervention for Latinos With Adv Cancer No drug interventions supportive_care Not Available recruiting NCT04985604
Tovorafenib (DAY101) Monotherapy or in Combination With Other Therapies for Patients With Melanoma and Other Solid Tumors treatment 1 / 2 recruiting NCT05174585
JAB-BX102 Monotherapy and Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT05544552
Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations No drug interventions treatment 1 / 2 recruiting NCT06259552
A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors No drug interventions treatment 1 recruiting NCT06326242
What Unmet Need for the Patients?A Focus on the Social Determinants of Health in Phase 1 Clinical Trials No drug interventions Not Available Not Available recruiting NCT06327997
An Exploratory Study by Fast CAR T Cells No drug interventions treatment 0 recruiting NCT06332430
Intratumoral CAN2109 in Subjects With Solid Tumors or Lymphomas No drug interventions treatment 1 not_yet_recruiting NCT00638898
Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor treatment 1 active_not_recruiting NCT04107311
Prospective Analysis of Intestinal Microbiome and Autoimmune Panels as Predictors of Toxicity in ImmunOncology Patients No drug interventions Not Available Not Available recruiting NCT04665388
LANDscape MApping of Epitopes and T Cell Receptors for Selected Cancers No drug interventions Not Available Not Available recruiting NCT04729348
Pembrolizumab And Lenvatinib In Leptomeningeal Metastases treatment 2 terminated NCT04827576
Study of Magrolimab in Patients With Solid Tumors treatment 2 active_not_recruiting NCT04903873
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05037149
Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors treatment 1 active_not_recruiting NCT03944499
Phase 1 Study of FS-1502 in Patients With HER2 Expressed Advanced Solid Tumors and Breast Cancer. treatment 1 active_not_recruiting NCT04172597
A Study of Poziotinib in Patients With Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Activating Mutations in Advanced Malignancies treatment 2 terminated NCT04243720
Immune Resistance Interrogation Study No drug interventions Not Available Not Available recruiting NCT04695327
TNFα and IL-2 Coding Oncolytic Adenovirus TILT-123 Monotherapy treatment 1 recruiting NCT04659629
NL-201 Monotherapy and in Combination With Pembrolizumab in Patients With Relapsed or Refractory Cancer treatment 1 active_not_recruiting NCT05357651
A Study to Assess the Safety and Efficacy of LB1410 in Participants With Advanced Solid Tumor or Lymphoma（Keyplus-001） No drug interventions treatment 1 recruiting NCT05547906
Evaluation of the Safety and Efficacy of ASCA101 in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT05661201
NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors treatment 1 recruiting NCT05798026
A Phase 1 Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of EU103 in Advanced or Metastatic Solid Tumors That Have Failed Standard Therapy No drug interventions treatment 1 recruiting NCT06307249
Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA treatment 1 recruiting NCT03195478
A Study of Nivolumab in Combination With Ipilimumab in Chinese Participants With Previously Treated Advanced or Recurrent Solid Tumors treatment 1 / 2 completed NCT03517917
Prospective Tissue Collection Research Protocol No drug interventions Not Available Not Available recruiting NCT03905538
Evaluation of [18F]FLT PET/CT as an Early Predictor of Outcome in Pediatric Solid Tumors No drug interventions diagnostic 0 withdrawn NCT04419532
A Study Evaluating DS-1055a in Participants With Relapsed or Refractory Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT04552418
Intestinal Microbiome Modification With Resistant Starch in Patients Treated With Dual Immune Checkpoint Inhibitors No drug interventions basic_science 0 completed NCT04780217
Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors treatment 1 / 2 active_not_recruiting NCT04977167
Clinical Trial of HG146 Administered to Subjects With Advanced Solid Tumors or Lymphoma No drug interventions treatment 1 recruiting NCT05076760
MEM-288 Oncolytic Virus Alone and in Combination With Nivolumab in Solid Tumors Including Non-Small Cell Lung Cancer treatment 1 recruiting NCT05206942
Serial Ultrasound of Solid Tumor Lesions to Detect Early Response to Cancer Immunotherapy No drug interventions diagnostic Not Available recruiting NCT05322408
HCW9218 in Select Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT05391022
Study Evaluating Food Effect and QTc in Patients With Advanced Malignancies treatment 1 completed NCT05732350
Exploratory Drug Interaction Study Between SMIs and DOACs No drug interventions Not Available Not Available completed NCT05749432
A Phase I Study of Hemay181 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05990920
Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy No drug interventions treatment 1 active_not_recruiting NCT06101082
A Clinical Study Evaluating the Safety and Efficacy of Anti-HER2-CAR-T Cells Injection in Patients With Solid Tumors treatment 1 recruiting NCT06237413
A Study of ZG2001 in Participants With KRAS Mutated Advanced Solid Tumours No drug interventions treatment 1 / 2 recruiting NCT06297525
Study of STP938 in Advanced Solid Tumours No drug interventions treatment 1 not_yet_recruiting NCT03740256
Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors No drug interventions treatment 1 recruiting NCT04175847
A Phase I /IIa Study of RC88-ADC in Subjects With Advanced Malignant Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT04410224
Study of ASN004 in Patients With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT05248074
To Evaluate the Safety, Pharmacokinetic and the Effect of Food After Administration of ABN401 in Healthy Adult Volunteers No drug interventions treatment 1 completed NCT05701306
APG-115 Alone or in Combination With APG-2575 in Children With Recurrent or Refractory Neuroblastoma or Solid Tumors treatment 1 recruiting NCT06039137
The Effect of Switching the H1-antagonist Clemastine to Cetirizine in Premedication Regimens During Paclitaxel Treatment Not Available Not Available completed NCT06075849
Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent No drug interventions treatment 1 recruiting NCT04675996
First-in-Human Study of INT-1B3 in Patients With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT05359718
The Psychological Impact of COVID-19 on Patients With Solid Malignancies: A Single-Institution Survey Study No drug interventions Not Available Not Available completed NCT05375084
SHP2 Inhibitor BBP-398 in Combination With Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer With a KRAS Mutation treatment 1 recruiting NCT05704985
Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors treatment 1 recruiting NCT06248697
Exploratory Study of MSLN-CAR T Cells Secreting PD1/CTLA-4 Nanoantibody for the Treatment of Advanced Solid Tumors No drug interventions treatment 0 recruiting NCT06249256
An Exploratory Study on the Treatment of Advanced Solid Tumors by Fast CAR T Cells No drug interventions treatment 0 recruiting NCT03838042
INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies treatment 1 / 2 recruiting NCT04071756
Topical Tazarotene Vs Placebo In Hand-Foot-Skin Reactions treatment 2 terminated NCT04064359
Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors No drug interventions treatment 1 recruiting NCT06241898
A First-in-human of Multiplle Doses of BB-1709 in Subjects With Locally Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT06245018
A Trial to Evaluate the Safety and Preliminary Efficacy of iNK in the Treatment of Subjects With Solid Tumor No drug interventions treatment Not Available not_yet_recruiting NCT05390710
PhI to Solid Tumors and PhII to Locally Advanced or mTNBC treatment 1 completed NCT05512208
A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib treatment 2 recruiting NCT05150405
A Phase Ia Clinical Study of QLF31907 Injection in Patients With Advanced Malignant Tumors No drug interventions treatment 1 recruiting NCT05436093
CLDN18.2 Targeting Nanobody Probe for PET Imaging in Solid Tumors screening Not Available recruiting NCT05576961
Safety and Efficacy of RX-af01 Combined With PD-1 Antibody treatment 1 / 2 recruiting NCT06215846
A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With Malignant Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT06220318
Assessment of the Safety and Efficacy of C019199 Plus Sintilimab in Participants With Advanced Solid Tumors treatment 1 / 2 recruiting NCT03992131
A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Participants With a Solid Tumor (SEASTAR) treatment 1 / 2 terminated NCT04242147
A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of KD033 (SAR445710) in Subjects With Metastatic or Locally Advanced Solid Tumors No drug interventions treatment 1 terminated NCT05480904
Characterizing Sleep Among Long-term Survivors of Childhood Cancer No drug interventions Not Available Not Available recruiting NCT06166888
A Study of AK131 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06166836
a Study to Evaluate the Safety and Efficacy of D-1553 Combined With IN10018 in KRAS G12C Mutant Solid Tumors treatment 1 / 2 recruiting NCT06198426
A Study of IBI3004 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 not_yet_recruiting NCT06209385
A Phase 1 Study of YZJ-5053 Tablets in Participants With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT03875287
Dose-Escalation Study of E7727, an Oral Cytidine Deaminase Inhibitor With Oral Decitabine in Subjects With Solid Tumors other 1 active_not_recruiting NCT05494762
Safety, Pharmacokinetics, and Antitumor Activity of BGB-B167 Alone and in Combination With Tislelizumab (BGB-A317) in Participants With Advanced Solid Tumors treatment 1 active_not_recruiting NCT06190886
A First-in-human (FIH), Multicenter, Open-Label, Phase I Study of PTX-912 in Patients With Locally Advanced/Metastatic Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT04021277
PS101-mediated ACT With Chemotherapy in Liver Metastases From Cancer of Gastrointestinal Origin No drug interventions treatment 1 recruiting NCT04235101
Phase I Study of SYD985 With Niraparib in Patients With Solid Tumors treatment 1 completed NCT04249843
Study of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants With Advanced or Refractory Tumors No drug interventions treatment 1 recruiting NCT04648254
Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor in Patients With Advanced Solid Tumor No drug interventions treatment 1 recruiting NCT04776005
COVID-19 Vaccine Efficacy in Patients With Malignant Pathologies No drug interventions Not Available Not Available recruiting NCT05770037
DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Teenage/Young Adults (TYA) and Paediatric Patients With ALK Positive Cancers treatment 2 / 3 recruiting NCT06184035
A Dose Escalation and Expansion Study of [177Lu]Lu-SN201 in Participants With Advanced Cancer treatment 1 / 2 recruiting NCT04944888
GSL Synthetase Inhibitor in Combination With Immune Checkpoint Inhibitor in Previously Treated Blood and Solid Tumor treatment 1 completed NCT04987112
Intratumoral CAN1012(Selective TLR7 Agonist) in Subjects With Solid Tumors No drug interventions treatment 1 recruiting NCT05217693
A First-in-human of Multiplle Doses of BB-1705 in Subjects With Locally Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT05430360
Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for the Treatment of Metastatic/Recurrent Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05497453
A Phase 1/2 Study to Evaluate OTX-2002 in Patients With Hepatocellular Carcinoma and Other Solid Tumor Types Known for Association With the MYC Oncogene treatment 1 / 2 recruiting NCT04365413
A Feasibility Study for the Use of Multispectral Optoacoustic Tomography in the Detection of Tumors No drug interventions diagnostic Not Available completed NCT04407741
Phase â… /â…¡ Study of SHR2554 in Combination With SHR1701 in Patients With Advanced Solid Tumors and B-cell Lymphomas treatment 1 / 2 recruiting NCT04111107
Precision Medicine for Patients With Identified Actionable Mutations No drug interventions treatment 2 terminated NCT05490264
[68Ga]Ga-NOTA-SNA002 (PD-L1 PET Tracer) for PET/CT in Patients With Solid Tumors No drug interventions diagnostic 0 recruiting NCT04301011
Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors treatment 1 / 2 terminated NCT05322512
Nectin-4 Targeting ADC Probe for PET Imaging in Solid Tumors diagnostic Not Available not_yet_recruiting NCT05923008
A Clinical Study of IBI130 for Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT06016062
A Study of RC148 in Patients With Locally Advanced Unresectable or Metastatic Malignant Solid Tumors No drug interventions treatment 1 recruiting NCT06150885
A Safety And Efficacy Study Of Allogeneic CAR Gamma-Delta T Cells in Subjects With Relapsed/Refractory Solid Tumors No drug interventions treatment 1 / 2 not_yet_recruiting NCT06145802
Clinical Study of Autologous Tumor Infiltrating Lymphocyte Injection (GT316) in the Treatment of Advanced Solid Tumors (Gynecological Tumors) No drug interventions treatment Not Available recruiting NCT04671901
A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors treatment 2 terminated NCT05245136
Augsburg Longitudinal Plasma Study for the Evaluation of Liquid Biopsy as Diagnostic Tool. No drug interventions Not Available Not Available recruiting NCT05868226
PRE-I-SPY Phase I/Ib Oncology Platform Program treatment 1 recruiting NCT06134960
NKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumor No drug interventions treatment 1 not_yet_recruiting NCT02054806
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-028/KEYNOTE-28) treatment 1 completed NCT04300556
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types treatment 1 / 2 recruiting NCT04911907
Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid Tumors treatment 2 recruiting NCT05221385
Gentulizumab in Patients With Advanced Solid Malignancies and Non-Hodgkin Lymphoma treatment 1 terminated NCT05914142
Study on the Safety and Effectiveness of Varian ProBeam Proton Therapy Equipment in the Treatment of Solid Tumors No drug interventions treatment Not Available completed NCT06112041
The Prospective Clinical Study of Precision PRaG Therapy in Elderly Patients With Advanced Solid Malignant Tumors (PRaG9.0) treatment 2 not_yet_recruiting NCT06117566
A Study of WX390 Combined With Toripalimab in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT02193503
MVX-ONCO-1 in Patients With Solid Tumor No drug interventions treatment 1 active_not_recruiting NCT02718911
A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors treatment 1 completed NCT03129139
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelideâ„¢ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors treatment 1 recruiting NCT03099109
A Study of LY3321367 Alone or With LY3300054 in Participants With Advanced Relapsed/Refractory Solid Tumors No drug interventions treatment 1 completed NCT03884556
TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers treatment 1 completed NCT04171700
A Study to Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes treatment 2 terminated NCT05120375
Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients in China No drug interventions treatment 1 terminated NCT05238792
Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients With High Risk Solid Tumors No drug interventions treatment 1 recruiting NCT05379946
Study to Evaluate D-1553 in Combination With IN10018 in Subjects With Solid Tumors treatment 1 / 2 recruiting NCT05716919
Multiple Ascending Dose Study of CG200745 'Ivaltinostat' Oral Capsule treatment 1 active_not_recruiting NCT05768178
DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. treatment 2 / 3 recruiting NCT05907980
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors treatment 1 recruiting NCT06004713
Registry Study in MSI/dMMR Solid Tumors No drug interventions Not Available Not Available recruiting NCT06041035
A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors treatment 1 / 2 not_yet_recruiting NCT06065592
Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms prevention 1 recruiting NCT06102837
Tumor Vaccines for Solid Tumors No drug interventions Not Available Not Available recruiting NCT06104488
A Study of Avutometinib for People With Solid Tumor Cancers treatment 1 recruiting NCT03953235
A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens treatment 1 / 2 completed NCT03891706
Individualized Tumor Specific TCR- T Cells in the Treatment of Advanced Solid Tumors treatment 1 recruiting NCT05163028
A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations No drug interventions treatment 1 recruiting NCT05485974
A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation No drug interventions treatment 1 recruiting NCT05176509
A Study to Evaluate the Combination of YH003, YH001 and Pembrolizumab in Subjects With Advanced Solid Tumors treatment 1 recruiting NCT04370587
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors treatment 1 / 2 recruiting NCT06022289
Pemigatinib for FGF/FGFR Alterations Advanced Pan Solid Tumors treatment 2 recruiting NCT02959619
Ensartinib in Non-small Cell Lung Cancer Patients With Positive ALK treatment 1 completed NCT03139370
Safety and Efficacy of MAGE-A3/A6 T Cell Receptor Engineered T Cells (KITE-718) in HLA-DPB1*04:01 Positive Adults With Advanced Cancers treatment 1 terminated NCT03990454
Safety Study of SLC-391 in Subjects With Solid Tumors treatment 1 completed NCT05103631
Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors No drug interventions treatment 1 recruiting NCT05119998
A Phase I Study of IBI325 in Patients With Advanced Solid Tumor treatment 1 completed NCT05767684
Neoantigen Derived DCs as Cancer Treatment treatment 1 recruiting NCT06008483
A Dose Finding Study to Treat Bone Tumor(s) treatment 1 recruiting NCT06009835
DOTr/DOTa Algorithm Guidance for Refractory Solid Tumors No drug interventions Not Available Not Available recruiting NCT04965220
HLX208 (BRAF V600E Inhibitor) in Combination With Trametinib in Patients With Advanced Solid Tumors treatment 1 recruiting NCT05982522
IN10018 Combination Therapy in Previously-treated Solid Tumors treatment 1 / 2 not_yet_recruiting NCT05971589
A Clinical Study on LM103 Injection for the Treatment of Advanced Solid Tumors No drug interventions treatment 0 not_yet_recruiting NCT05971576
A Clinical Study on TILs for the Treatment of Advanced Solid Tumors No drug interventions treatment 0 not_yet_recruiting NCT05134636
Text-based Intervention to Minimize the Time Burden of Routine Cancer Care No drug interventions health_services_research Not Available completed NCT05828459
First-in-human Study of OT-A201 in Patients With Selected Hematological Malignancies and Solid Tumors treatment 1 recruiting NCT04105777
Trial Comparing Parenteral Nutrition (PN) Using Eurotubes® vs. 2/3-chamber Bags in Subjects With Solid Tumors Requiring PN (PEKANNUSS) No drug interventions Not Available Not Available terminated NCT02861300
CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal Cancer treatment 1 / 2 active_not_recruiting NCT03447470
Study to Evaluate the Safety and Tolerability of RXC004 in Advanced Malignancies treatment 1 active_not_recruiting NCT04942717
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values No drug interventions Not Available Not Available recruiting NCT05708950
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) treatment 1 / 2 recruiting NCT05798533
Neo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03) treatment 1 recruiting NCT05940181
A Safety and Efficacy Study of XH001 Combined With Sintilimab Injection in Advanced Solid Tumors treatment Not Available recruiting NCT05941936
A Clinical Study on LM103 for the Treatment of Advanced Solid Tumors No drug interventions treatment 0 recruiting NCT05943041
Live Biotherapeutic Product GB104 Phase 1 Study in Colorectal Cancer No drug interventions treatment 1 recruiting NCT03989115
Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLC treatment 1 / 2 completed NCT03333031
A Study of HS-196, an HSP90 Inhibitor-linked NIR Probe for Solid Malignancies No drug interventions other 1 terminated NCT04900818
Study of TJ033721 in Subjects With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT05909436
Immuno-Oncology Drugs GLS-012 Alone & in Combination GLS-010 Treating With Advanced Patients Solid Tumors treatment 1 / 2 recruiting NCT01752920
Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations treatment 1 / 2 completed NCT02986100
Absorption, Metabolism, and Excretion Following a Single Oral Dose of [14C]-Rucaparib other 1 completed NCT05784688
Study of TU2218 in Combination With Pembrolizumab in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT05869240
BPB-101 in Subjects With Metastatic or Locally Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05895370
HPV-T in HPV-16 Positive Recurrent or Metastatic Solid Tumors treatment 1 recruiting NCT05898451
Effect of Refnot on Immunity in Cancer Patients treatment 2 completed NCT03781219
A PhaseI Study of HL-085 Plus Vemurafenib in Solid Tumor With BRAF V600 Mutation treatment 1 recruiting NCT05207787
Phase â… /â…¡ Study of the HS-10365 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT03536728
Oral AMXT 1501 Dicaprate in Combination With DFMO treatment 1 completed NCT03994211
Study to Investigate the Effect of Rifampin and Itraconazole on the Action of Pamiparib in Participants With Cancer basic_science 1 completed NCT04485416
Pilot Trial of Eltrombopag in Patients Undergoing Chemotherapy for Malignant Solid Tumors supportive_care 1 recruiting NCT03364400
Phase 1 Study Evaluating VT1021 in Patients With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT04720976
JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT05336279
Bioequivalence Study of Famitinib Malate in Healthy Volunteers Under Fasting Condition No drug interventions basic_science 1 completed NCT05359354
Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Solid Tumors No drug interventions treatment Not Available recruiting NCT04386967
OH2 Injection in Solid Tumors treatment 1 / 2 recruiting NCT05843305
A Study of BPI-452080 in Subjects With Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT03802955
Study of ADG106 With Advanced or Metastatic Solid Tumors and/or Non-Hodgkin Lymphoma No drug interventions treatment 1 completed NCT04144842
Phase 1 Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of ATOR-1017 No drug interventions treatment 1 completed NCT05828238
Positron Emission Tomograph(PET) Imaging Explores the Role of SF-DEVD-2 in Monitoring Tumor Efficacy No drug interventions diagnostic 0 recruiting NCT05831033
Safety and Efficacy of an Autologous Tumor Infiltrating Lymphocyte (TIL) Therapy in Patients With Advanced Solid Tumors No drug interventions treatment 0 not_yet_recruiting NCT05833984
Safety and Efficacy of IMM01 Plus Tislelizumab in Patients With Advanced Solid Tumors and Lymphomas treatment 1 / 2 recruiting NCT04348643
Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer No drug interventions treatment 1 / 2 recruiting NCT04511871
A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors No drug interventions treatment 1 recruiting NCT04696848
The Efficacy and Safety of CKD516 Combined With Durvalumab in Patient Refractory Solid Tumors treatment 1 / 2 terminated NCT04991506
A Study of ES102 (OX40 Agonist) in Combination With JS001 in Patients With Advanced Solid Tumors treatment 1 recruiting NCT03758781
IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors treatment 1 completed NCT04363242
A Study to Find the MTD of SYN125 in People With Solid Tumors and the MTD of SYN125 With a Fixed Dose of SYN004 in People in Patients With Epithelial Cancers With EGFR Expressions treatment 1 active_not_recruiting NCT05126927
A PET Imaging Agent to Assess the Level of Tumor Tissue-infiltrating CD8 + T Cells in Patients With Solid Tumors No drug interventions diagnostic 0 completed NCT05278364
Phase I/II Study of SY-5007, a RET Inhibitor, in Patients With RET-altered Advanced Solid Tumor No drug interventions treatment 1 / 2 recruiting NCT05361954
Study to Assess the Safety and Preliminary Efficacy of STI-1386 Oncolytic Virus in Relapsed or Refractory Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT05798546
Treatment of Advanced Solid Tumors With Neo-T(GI-NeoT-02) treatment 1 recruiting NCT04214730
Study of NK Combined With Chemotherapy for Advanced Solid Tumor No drug interventions treatment Not Available recruiting NCT04196257
BP1001-A in Patients With Advanced or Recurrent Solid Tumors treatment 1 recruiting NCT04214717
Study of DC-CIK Combined With Chemotherapy for Advanced Solid Tumor No drug interventions treatment Not Available recruiting NCT04542863
The Molecular Imaging Research of F-18 Labeled DX600 PET Probe No drug interventions diagnostic Not Available recruiting NCT05144698
RAPA-201 Therapy of Solid Tumors treatment 1 / 2 recruiting NCT02534649
Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials No drug interventions diagnostic Not Available recruiting NCT02742935
A Study to Evaluate the Safety and Tolerability of Using SHR-1210 by Advanced Solid Tumor Subjects treatment 1 completed NCT04452955
A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid Tumors No drug interventions treatment 2 recruiting NCT05745454
A Clinical Study on the Safety and Efficacy of Chimeric Antigen Receptor T-cell (CART) in the Treatment of Solid Tumors No drug interventions treatment Not Available not_yet_recruiting NCT04547205
A Study of Anti-VEGFR2 AK109 in Subjects With Advanced Solid Tumors treatment 1 completed NCT05741242
Basket Trial of Neoantigen Synthetic Long Peptide Vaccines in Patients With Advanced Malignancy No drug interventions treatment 1 / 2 enrolling_by_invitation NCT04013217
Evaluate Eribulin ORA in Subjects With Solid Tumors treatment 1 terminated NCT04930354
ECP-1014 Treatment for Patients With Solid Tumor Cancers No drug interventions treatment 1 recruiting NCT04970121
Efficacy and Safety of Duloxetine in Chinese Solid Tumor Patients With Taxanes-induced Painful Peripheral Neuropathy treatment 2 recruiting NCT05724732
Exploratory Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Gynecologic Tumors No drug interventions treatment 0 recruiting NCT05230290
Clinical Study of KD6001 in Advanced Solid Tumours No drug interventions treatment 1 completed NCT05583201
NKG2D/CLDN18.2 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumors No drug interventions treatment 0 recruiting NCT04158336
A Study of ZN-c3 in Participants With Solid Tumors treatment 1 recruiting NCT04202705
A First-in-human Dose-escalation and Expansion Study With the Antibody-drug Conjugate SYD1875 No drug interventions treatment 1 completed NCT01607905
Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer treatment 1 completed NCT05100251
Clinical Trial of WB100 on Advanced Solid Tumor No drug interventions treatment 1 recruiting NCT04900519
Study of the Safety and Efficacy of STI-6643 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05691608
MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2 diagnostic Not Available recruiting NCT05649618
TIL Cells for the Treatment of the Advanced Solid Tumors Patients treatment 0 not_yet_recruiting NCT05638828
A Study of RD14-01 in Patients With Advanced Solid Tumors No drug interventions treatment 0 not_yet_recruiting NCT05539183
Collection of Pleural Effusion Fluid No drug interventions basic_science Not Available not_yet_recruiting NCT05534178
Machine Learning Model to Predict HOLS and Mortality After Discharge in Hospitalized Oncologic Patients No drug interventions Not Available Not Available recruiting NCT05528406
A Phase II Clinical Trial to Evaluate HLX208 in Advanced Solid Tumor Patients With BRAF V600 Mutation No drug interventions treatment 2 not_yet_recruiting NCT05528055
A Study to Investigate the Safety and Tolerability of SCR-6920 Capsule in Patients With Advanced Malignant Tumors treatment 1 recruiting NCT05525767
Chemotherapy Combined With Bevacizumab Neoadjuvant Therapy for HER2-negative Breast Cancer treatment 4 recruiting NCT05512780
Dalpiciclib Combined With Letrozole in Neoadjuvant Treatment of Stage â…¡-â…¢ HR-positive/HER2-negative Breast Cancer treatment 2 not_yet_recruiting NCT05440006
A Study of Food Effect on the Pharmacokinetics of Fuzuloparib Capsules in Chinese Healthy Adult Subjects No drug interventions treatment 1 completed NCT05437315
GD2/PSMA Bi-specific CAR-T Cell Therapy No drug interventions treatment 1 / 2 recruiting NCT05390944
An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fasting Condition other 1 not_yet_recruiting NCT05382377
NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors treatment 0 recruiting NCT05373147
αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors No drug interventions treatment 0 recruiting NCT05369312
Phase 1 Study of BPI-442096 in Advanced Solid Tumor Patients No drug interventions treatment 1 not_yet_recruiting NCT05357911
A Study on the Effect of AB-106 on the Pharmacokinetics of Digoxin treatment 1 completed NCT05357820
A Study of AB-106 in Chinese Healthy Adult Men Evaluated the Effects of Itraconazole and Rifampicin on AB-106 PK treatment 1 completed NCT05274191
An Exploratory Basket Study of Pyrotinib Maleate Tablets in HER2 Mutated or Amplified of Metastatic Solid Tumors No drug interventions treatment 2 not_yet_recruiting NCT05228600
YL-13027 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05212987
Study of FCN-098 in Patients With Advanced Solid Tumor No drug interventions treatment 1 recruiting NCT05198752
A Study of Neoantigen mRNA Personalised Cancer in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05196360
MAX-10181 in Patients With Advanced Solid Tumor No drug interventions treatment 1 recruiting NCT05173142
HMPL-453 (FGFR Inhibitor) in Combination With Chemotherapy or Anti-PD-1 Antibody in Advanced Solid Tumors treatment 1 / 2 recruiting NCT05166070
An Exploratory Clinical Study of RD133 in Subjects With Relapsed or Refractory MSLN-Positive Solid Tumors No drug interventions treatment 0 recruiting NCT05165849
A Study of GFS101A in Combination With Toripalimab in Patients With Advanced Solid Tumors treatment 1 / 2 withdrawn NCT05136937
A Clinical Study of Intratumoral Administration of RT-01 in Patients With Advanced Solid Tumors treatment 1 recruiting NCT05115500
ADC Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of HER-2 Positive Advanced Solid Tumors(PRaG3.0) No drug interventions treatment 2 not_yet_recruiting NCT05109832
A Study of Absorption-Distribution-Metabolism-Excretion (ADME) of [14C]IMP4297 to China Healthy Male Subjects other 1 not_yet_recruiting NCT05095441
A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma No drug interventions treatment 1 not_yet_recruiting NCT05058937
A Study to Examine the Clinical Value of Comprehensive Genomic Profiling Performed by Belgian NGS Laboratories: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Centre No drug interventions diagnostic Not Available recruiting NCT05046847
A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3811 Tablets in Patients With Advanced Malignant Tumors No drug interventions treatment 1 recruiting NCT05025358
A Study of LP-118 in Patients With Advanced Tumors No drug interventions treatment 1 recruiting NCT05019794
Infigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR Alterations treatment 2 recruiting NCT04930432
Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT04910633
Medical Treatment of Solid Tumors at the Lyon University Hospital Cancer Institute During the First Wave of COVID-19 in France: A Conservative Approach No drug interventions Not Available Not Available completed NCT04873440
An Open-label, Phase I/II Study of Manganese Plus Radiotherapy in Patients With Metastatic Solid Tumors or Lymphoma treatment 1 / 2 recruiting NCT04866485
A Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combined With Anti-PD-1 Antibody treatment 1 not_yet_recruiting NCT04848493
National Project on Vaccines, COVID-19 and Frail Patients No drug interventions Not Available Not Available recruiting NCT04841421
Clinical Study on PET Imaging, Distribution and PK of 89Zr-CD147 in Patients With Solid Tumors No drug interventions diagnostic 0 not_yet_recruiting NCT04810208
Intratumoural Injection of a Novel NanoZolid®-Docetaxel Depot Formulation in Patients With Advanced Solid Tumours treatment 1 terminated NCT04809012
Study of STI-3031 in Patients With Selected Relapsed or Refractory Solid Tumors treatment 2 withdrawn NCT04762862
QUANTACT : Impact of Pangenomic QUANTitative Alterations in Cancer Therapy No drug interventions Not Available Not Available enrolling_by_invitation NCT04743388
Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune System Not Available Not Available recruiting NCT04691713
CD276 CAR-T for Patients With Advanced CD276+ Solid Tumors No drug interventions treatment Not Available unknown_status NCT04679038
A Trial of SHR-1701 in Combination With Famitinib in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT04673396
Phase I Clinical Study for Evaluation of Pharmacokinetic, Safety, Tolerance of Norcantharidin Lipid Microsphere for Injection in Patients With Solid Tumor No drug interventions treatment 1 unknown_status NCT04647838
Tepotinib in Solid Tumors Harboring MET Alterations treatment 2 recruiting NCT04644107
Expanded Access for Marizomib Not Available Not Available no_longer_available NCT04617054
Basket Study of AB-106 for the Treatment of Patients With Solid Tumors With NTRK Fusion Gene No drug interventions treatment 2 recruiting NCT04588324
Study of SHR2150 (TLR7 Agonist) in Combination With Chemotherapy Plus PD-1 or CD47 Antibody in Subjects With Unresectable/ Metastatic Solid Tumors No drug interventions treatment 1 / 2 unknown_status NCT04584515
IMP4297 DDI (Drug-Drug Interaction)Trial in Healthy Male Volunteers other 1 completed NCT04571632
Clinical Trial of SBRT and Systemic Pembrolizumab With or Without Avelumab/Ipilimumab+ Dendritic Cells in Solid Tumors treatment 2 recruiting NCT04569916
Radiotherapy Combined With Irinotecan and Apatinib Followed by PD-1 Antibody and Apatinib for Advanced Solid Tumors treatment 2 not_yet_recruiting NCT04550663
NKG2D CAR-T(KD-025) in the Treatment of Relapsed or Refractory NKG2DL+ Tumors treatment 1 not_yet_recruiting NCT04526470
Alpelisib and Paclitaxel in PIK3CA-altered Gastric Cancer treatment 1 / 2 recruiting NCT04496375
An Evaluation of Patients Access to Their Electronic Medical Records Via the IPC Connect Application No drug interventions Not Available Not Available unknown_status NCT04478916
Impact of the Comprehensive Geriatric Assessment on the Quality of Life OF Elderly Patients No drug interventions Not Available Not Available unknown_status NCT04477057
Phaseâ… Study of the HS-10241 in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT04475705
Propofol vs Sevo for Paediatric Tumor Surgery treatment 4 recruiting NCT04432649
Targeting CD276 (B7-H3) Positive Solid Tumors by 4SCAR-276 No drug interventions treatment 1 / 2 recruiting NCT04413227
A Phase Ib Study With Pegylated Recombinant Human Endostatin in Advanced / Metastatic NSCLC or Other Solid Tumors treatment 1 unknown_status NCT04407897
SOFT- Stereotactic Ablative Radiotherapy of Infra-diaphragmatic Soft Tissue Metastases No drug interventions treatment Not Available active_not_recruiting NCT04397575
The GCO-002 CACOVID-19 Cohort: a French Nationwide Multicenter Study of COVID-19 Infected Cancer Patients No drug interventions Not Available Not Available completed NCT04367467
Effect of PARP Inhibitors on Glomerular Filtration Rate No drug interventions Not Available Not Available terminated NCT04360317
Safety of the Combination of SH003 and Docetaxel in Patients With Solid Cancer treatment 1 unknown_status NCT04347226
Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19 No drug interventions treatment 2 terminated NCT04300088
A Prospective Study of the Relevance of the HLA-G Immune Checkpoint in Cancer Immunotherapy No drug interventions Not Available Not Available not_yet_recruiting NCT04264767
Characterization of Methylation Patterns in Cancer and Non-Cancer cfDNA No drug interventions Not Available Not Available completed NCT04228406
Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy Evaluation of GST-HG161 No drug interventions treatment 1 unknown_status NCT04209465
A Study of BDTX-189, an Orally Available Allosteric ErbB Inhibitor, in Patients With Advanced Solid Tumors. No drug interventions treatment 1 / 2 terminated NCT04183764
MAX-40279-01 in Patients With Advanced Solid Tumors treatment 1 recruiting NCT04180384
A Safety Study of Oraxol (HM30181 + Oral Paclitaxel) in Cancer Patients treatment 2 completed NCT04179656
The Basket Study of Pyrotinib Maleate for HER2-Postive Solid Tumor treatment 2 unknown_status NCT04172506
A Study to Evaluate the Efficacy and Safety of Anti-PD-1 Antibody AK105 in Patients With Selected Advanced Solid Tumors treatment 1 / 2 completed NCT04151329
A Phase I Clinical Trial of BAT1306 and BAT8001 Injection in Patients With Solid Tumor No drug interventions treatment 1 / 2 unknown_status NCT04122339
MAX-10181 Given Orally to Patients With Advanced Solid Tumor No drug interventions treatment 1 recruiting NCT04111445
Study of ADG116 in Patients With Advanced/Metastatic Solid Tumors No drug interventions treatment 1 terminated NCT04099277
A Study of LY3435151 in Participants With Solid Tumors treatment 1 terminated NCT04082910
Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells treatment 1 / 2 recruiting NCT04079283
Radiomics of Immunotherapeutics Response Evaluation and Prediction No drug interventions Not Available Not Available completed NCT04057729
IMP4297 Food Effect Trial in Healthy Volunteers other 1 completed NCT04046016
A Study Using Whole-body PET After Oral Microdose of 18F-labeled Liporaxel in Patients With Solid Tumor treatment 0 completed NCT04035473
A Study to Determine the Bioequivalence of Oraxol in Cancer Patients Treated With Intravenous Paclitaxel treatment 1 completed NCT04001569
AZD8186 and Paclitaxel in Advanced Gastric Cancer treatment 1 / 2 recruiting NCT03993379
PROCLAIM: CX-072-002: Study of PD-L1 Probody Therapeutic CX-072 in Combination With Other Anticancer Therapy in Adults With Solid Tumors treatment 2 terminated NCT03991559
A Safety Study of the Pan-immunotherapy in Patients With Unresectable/Metastatic Solid Tumors or Lymphomas treatment 1 unknown_status NCT03987685
Evaluate Oral Topotecan With HM30181A Monotherapy in Patients With Advanced Malignancies treatment 1 completed NCT03980041
Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275) treatment 2 completed NCT03970382
A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors treatment 1 suspended NCT03961100
A Performance and Bioavailability Study of Entrectinib in Healthy Volunteers. treatment 1 completed NCT03916094
Evaluate Safety, Tolerability and Pharmacokinetics of HLX22 in Patients With Advanced Solid Tumors Overexpressing HER2 No drug interventions treatment 1 completed NCT03913741
A Trial of Tisotumab Vedotin in Japanese Subjects With Advanced Solid Malignancies treatment 1 / 2 completed NCT03906643
HS-201, an HSP90 Inhibitor-linked Verteporfin for Detection of Solid Malignancies No drug interventions other 1 withdrawn NCT03879057
Trial of Surufatinib Combined With JS001 in the Treatment of Advanced Solid Tumors treatment 1 unknown_status NCT03875313
Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors treatment 1 / 2 terminated NCT03844438
A Study Evaluating the Safety, Tolerability of LPM3480226 Tablets in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT03835949
Study of TJ004309 in Combination With Atezolizumab (Tecentriq®) in Patients With Advanced or Metastatic Cancer treatment 1 active_not_recruiting NCT03804515
A Mass Balance and Pharmacokinetics Study of 14C-Labeled Poziotinib in Cancer Patients Suitable for Treatment With Poziotinib treatment 1 terminated NCT03782467
Phase 1 Study in Patients With Advanced and/or Refractory Solid Malignancies to Evaluate the Safety of ATOR-1015 No drug interventions treatment 1 completed NCT03775525
Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer treatment 1 active_not_recruiting NCT03758664
Clinical Study of ICP-192 in Solid Tumors Patients No drug interventions treatment 1 / 2 recruiting NCT03757936
A Phase I Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Anti-PD-1 Antibody (HLX10) in Combination With Avastin Biosimilar (HLX04) in Patients With Advanced Solid Tumors treatment 1 unknown_status NCT03752177
A Study of LY3415244 in Participants With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT03733587
GX-I7 With Cyclophosphamide in Patients With Metastatic or Recurrent Solid Tumors treatment 1 completed NCT03673787
A Trial of Ipatasertib in Combination With Atezolizumab health_services_research 1 / 2 recruiting NCT03644056
Dose-escalation Study of IMC-001 in Subject With Metastatic or Locally-advanced Solid Tumors other 1 completed NCT03619616
Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose of ZSP1603 in Healthy Adults No drug interventions treatment 1 completed NCT03601611
Checkpoint Inhibitor Induced Colitis and Arthritis -Immunomodulation With IL-6 Blockade and Exploration of Disease Mechanisms treatment Not Available completed NCT03596593
Identifying MSI Status From ctDNA in Chinese Patients With Refractory Advanced Solid Tumors No drug interventions diagnostic Not Available unknown_status NCT03583125
Study of EOC317 in Chinese Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT03552406
Study of ISU104, Targeting ERBB3 in Patients With Advanced Solid Tumors treatment 1 active_not_recruiting NCT03468751
Phase 1 Study of HLX10, a Monoclonal Antibody Targeting Programmed Death-1 (PD-1) in Patients With Advanced Solid Tumors treatment 1 unknown_status NCT03447483
Cohort Study: Modelling Toxicity Processing in Patients Treated by Immunotherapy (MOTIVATE). No drug interventions other Not Available completed NCT03448211
A Study of PTS for Patients With Solid Tumors treatment 1 withdrawn NCT03406364
Assess the Safety and Activity of Combined MG005 and Sorafenib (NEXAVAR®) Treatment With Solid Tumor No drug interventions treatment 1 completed NCT03359850
Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment Patients treatment 1 completed NCT03343613
A Study of LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors No drug interventions treatment 1 terminated NCT03313219
Pharmacokinetics and Tolerancebility Studies of Gentuximab Injection in the Treatment ofPatients With Late Recurrence of Metastatic Solid Tumors in China No drug interventions treatment 1 unknown_status NCT03258099
Association of Genetic Polymorphisms With Capecitabine-based Chemotherapy Toxicities in Chinese Solid Tumor Patients No drug interventions Not Available Not Available unknown_status NCT03221400
PEN-866 in Patients With Advanced Solid Malignancies treatment 1 / 2 recruiting NCT03220854
SBRT + PD-1/PDL-1 Inhibiting Therapy for Advanced Solid Tumors After Dz Control on PD-1/PDL-1 Tx No drug interventions treatment 2 completed NCT03182257
Study of ONO-7579 in Patients With Advanced Solid Tumors/ NTRK Gene Fusion Positive Advanced Solid Tumors treatment 1 terminated NCT03181854
Randomized Controlled Trial of Integrated Early Palliative Care No drug interventions supportive_care Not Available completed NCT03182673
The Study of SHR7390 in Combination With SHR-1210 and SHR3162 in Patients With Advanced Solid Tumors treatment 1 terminated NCT03168061
Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma treatment 1 / 2 unknown_status NCT03166176
Phase II Trial of Vistusertib（AZD2014） Single Agent in TSC1or 2 Null or TSC 1/2 Mutation Solid Cancer Patients Refractory to Standard Chemotherapy treatment 2 withdrawn NCT03159585
To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors No drug interventions treatment 1 completed NCT03147976
QUILT-3.036: AMG 337 in Subjects With Advanced or Metastatic Solid Tumors treatment 2 withdrawn NCT03118817
Expansion Study to Evaluate the Efficacy and Safety of HM95573 in BRAF, KRAS or NRAS Mutant Solid Cancers No drug interventions treatment 1 completed NCT03109639
A Randomized Prospective Comparison of the New EUS Guided Acquire TM Needle Biopsy vs EUS Guided Fine Needle Aspiration for Suspected Solid Gastrointestinal Lesions No drug interventions diagnostic Not Available completed NCT03085914
A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723) treatment 1 / 2 completed NCT03080311
A Study of APG-1252 in Patients With SCLC or Other Solid Tumors treatment 1 completed NCT03062982
Food-Effect and Metabolism Study in Healthy Subjects other 1 completed NCT03057145
Combination Study of Prexasertib and Olaparib in Patients With Advanced Solid Tumors treatment 1 completed NCT03051477
Trial of Mistletoe Extract in Patients With Advanced Solid Tumors treatment 1 completed NCT03042910
A Study to Assess the Effects of Talazoparib on Cardiac Repolarization in Patients With Advanced Solid Tumors treatment 1 completed NCT03027128
QUILT-3.028: Study of haNKâ„¢ for Infusion in Subjects With Metastatic or Locally Advanced Solid Tumors treatment 1 completed NCT03015324
Biological Effects of Agent on PAR-4 Levels With Resected Solid Tumors treatment 1 completed NCT03013491
PROCLAIM-CX-072: A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas treatment 1 / 2 completed NCT03009292
Pharmacokinetic Study of E7080/Lenvatinib in Chinese Subjects With Solid Tumor treatment 1 completed NCT02992210
Study on GD2 Positive Solid Tumors by 4SCAR-GD2 No drug interventions treatment 1 / 2 unknown_status NCT02987166
HDCRT Plus Pembrolizumab in Advanced Malignancies treatment 1 completed NCT02974738
A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001) treatment 1 active_not_recruiting NCT02968485
Phase I Study of SHR7390 in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT02966171
A Dose Escalation Study to Assess the Safety and Tolerability of HMPL-453 in Patients With Advanced Solid Malignancies No drug interventions treatment 1 terminated NCT02953782
Study of Magrolimab (Hu5F9-G4) in Combination With Cetuximab in Participants With Solid Tumors and Advanced Colorectal Cancer treatment 1 / 2 completed NCT02890511
A Study DHP107, a Novel Oral Paclitaxel Formulation, in Patients With Advanced Solid Tumours or Gastric Cancer treatment 1 / 2 completed NCT02884128
A Study of PEP02 in Combination With 5-fluorouracil (5-FU) and Leucovorin (LV) in Advanced Solid Tumors treatment 1 completed NCT02877589
Interest of Routine Screening for Hepatitis B and C in Patients Receiving Chemotherapy for Solid Tumors No drug interventions Not Available Not Available completed NCT02784795
A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors treatment 1 completed NCT02715531
A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors treatment 1 completed NCT02656849
BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors treatment 2 withdrawn NCT02653196
A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors treatment 0 terminated NCT02648425
Safety and Tolerability of ASLAN001 in Combination With Cisplatin and 5-FU or Cisplatin and Capecitabine treatment 1 completed NCT02643303
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers treatment 1 / 2 completed NCT02608307
Medical Treatment Decision Making Using Adaptive Conjoint Analysis No drug interventions Not Available Not Available terminated NCT02593708
Phase1 of Neratinib+Trastuzumab, Pertuzumab, Paclitaxel in Patients With Advanced Solid Tumors/HER2+ treatment 1 terminated NCT02590952
A Phase I Study of Epitinib(HMPL-813) in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT02517918
Metronomic Chemotherapy in Patients With Advanced Solid Tumor With Bone Metastasis and Advanced Pretreated Osteosarcoma treatment 1 completed NCT02510001
MEK and MET Inhibition in Colorectal Cancer treatment 1 completed NCT02505165
Illness Management and Parental Adjustment to Cancer Treatment No drug interventions supportive_care Not Available completed NCT02490475
A Multiple-Dose Study of RhuMab 2C4 and Docetaxel in the Treatment of Advanced Solid Tumors treatment 1 completed NCT02488330
An Extension Study of Onartuzumab in Participants With Solid Tumors on Study Treatment Previously Enrolled in a Company Sponsored Study treatment 3 completed NCT02472977
Safety and Efficacy Study of Ulocuplumab and Nivolumab in Subjects With Solid Tumors other 1 / 2 terminated NCT02454010
A Dose Escalation Study of Radio-labeled Antibody for the Treatment of Advanced Cancer No drug interventions treatment 1 completed NCT02449538
Study to Evaluate the Safety and Efficacy of Everolimus, in Subjects With PIK3CA Amplification, PTEN Loss and PIK3CA Mutation Refractory Solid Tumors treatment 2 completed NCT02449564
The Pilot Study Evaluate the Safety and Efficacy of Sirolimus in Patients With PIK3CA Mutation and/or PIK3CA Amplification Refractory Solid Tumors treatment Not Available completed NCT02447419
Study to Evaluate the Safety and Efficacy of Gefitinib, in Subjects With EFGR Amplification Refractory Solid Tumors treatment 2 completed NCT02441543
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus No drug interventions Not Available Not Available completed NCT02428036
A Study of TBI-1401(HF10) in Patients With Solid Tumors With Superficial Lesions No drug interventions treatment 1 completed NCT02414516
A Dose-Escalation Study of OBP-801 in Patients With Advanced Solid Tumors treatment 1 unknown_status NCT02352844
Everolimus in Patients With Advanced Solid Malignancies With TSC1, TSC2, NF1, NF2, or STK11 Mutations treatment 2 completed NCT02280954
Indocyanine Green for Solid Tumors diagnostic 1 completed NCT02264613
ALRN-6924 in Patients With Advanced Solid Tumors or Lymphomas treatment 1 / 2 completed NCT02250157
A Dose-regimen Finding Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oratecan in Subjects With Advanced Malignancies treatment 1 completed NCT02250170
Safety and Biomarker of OPB-111077 in Subjects With Advanced Solid Tumor treatment 1 completed NCT02232243
HCQ on PAR-4 Levels in Patients With Resectable Solid Tumors treatment 1 completed NCT02220556
Evaluation of Different Analysis Methods for Circulating Tumor Cells, Circulating Endothelial Cell, and Circulating Tumor DNA in Patient Followed for a Tumoral Pathology No drug interventions diagnostic Not Available unknown_status NCT02216409
Phase 1 Trial of Hu5F9-G4, a CD47-targeting Antibody treatment 1 completed NCT02199548
The Good Patient Study No drug interventions Not Available Not Available completed NCT02161978
Vascular Dysfunction and Antiangiogenic Therapy No drug interventions Not Available Not Available completed NCT02160041
BGJ398 for Patients With Tumors With FGFR Genetic Alterations treatment 2 terminated NCT02150733
Pharmacokinetics of Tivantinib in Subjects With Advanced Solid Tumors and Hepatic Impairment treatment 1 completed NCT02132754
Study of MK-4166 and MK-4166 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4166-001) treatment 1 completed NCT02101164
Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease Not Available 4 withdrawn NCT02076230
A Phase 1 TH-302 Mass Balance Trial treatment 1 completed NCT02065297
Quantitative and Functional Study of TH17 Lymphocytes in Horton's Disease (HD) No drug interventions Not Available Not Available completed NCT02048709
Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Advanced Solid Tumors treatment 1 completed NCT02003092
RX-5902 Treatment of Subjects With Triple Negative Breast Cancer treatment 1 / 2 terminated NCT01981187
LGX818 for Patients With BRAFV600 Mutated Tumors treatment 2 terminated NCT01971515
First-in-Human Dose Escalation Trial in Subjects With Advanced Malignancies treatment 1 completed NCT01957735
BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors No drug interventions other 1 completed NCT01954355
LDE225 and Paclitaxel in Solid Tumors treatment 1 completed NCT01929941
An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies treatment 1 terminated NCT01875705
A Dose-Escalation Study of GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors other 1 completed NCT01840579
Study of Pembrolizumab (MK-3475) Monotherapy in Advanced Solid Tumors and Pembrolizumab Combination Therapy in Advanced Non-small Cell Lung Cancer/ Extensive-disease Small Cell Lung Cancer (MK-3475-011/KEYNOTE-011) treatment 1 completed NCT01833546
A Japanese Phase 1 Trial of TH-302 in Subjects With Solid Tumors and Pancreatic Cancer treatment 1 completed NCT01806376
A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics No drug interventions prevention 1 unknown_status NCT01798654
EUS-FNA for Patients With Antithrombotic Agents No drug interventions Not Available Not Available completed NCT01705002
Intravenously Administered Pegylated Liposomal Mitomycin-C Lipid-based Prodrug (PROMITIL) in Cancer Patients With Solid Tumors. treatment 1 completed NCT01683149
Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies treatment 1 completed NCT01682135
A Study in Participants With Advanced Solid Tumors treatment 1 completed NCT01648764
A Study of LY2334737 in Participants With Cancer That is Advanced and/or Has Spread treatment 1 completed NCT01641575
A Dose Ascending Study of Gemcitabine Elaidate (CO-101) in Combination With Cisplatin treatment 1 terminated NCT01588522
Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for Advanced or Recurrent Disease prevention 1 completed NCT01553071
Phase I Trial of IV Fenretinide (4-HPR) Plus IV Safingol for Patients With Relapsed Malignancies treatment 1 terminated NCT01540175
Immune Reconstitution in Oncology Patients Following Autologous Stem Cell Transplant No drug interventions Not Available Not Available completed NCT01473095
Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant Lymphoma treatment 1 completed NCT01463982
Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Malignancies treatment 1 completed NCT01432951
A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma other 1 completed NCT01428141
A Phase I Study of E7050 in Subjects With Solid Tumors treatment 1 completed NCT01415258
Screening for Vulnerability in the Elderly Supported at the Oscar Lambret Centre No drug interventions Not Available Not Available completed NCT01363024
Trial Evaluating the Safety and Pharmacokinetics of MFGR1877S in Patients With Advanced Solid Tumors treatment 1 completed NCT01336582
Pharmacokinetic Study of SYP-0704A and Taxotere to Treat Patient With Advanced Solid Cancer treatment 1 completed NCT01327313
A Study of EMD525797 in Solid Tumor Patients in Japan treatment 1 completed NCT01317927
A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies treatment 1 completed NCT01315431
A Study of Tesetaxel Plus Capecitabine in Patients With Solid Tumors treatment 1 unknown_status NCT01284192
Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma) treatment 1 completed NCT01240590
A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC) treatment 1 / 2 completed NCT01225536
Dose Escalation Study of ARQ 736 in Adult Subjects With Advanced Solid Tumors Harboring BRAF and/or NRAS Mutations No drug interventions treatment 1 completed NCT01170897
Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid Tumors Not Available 1 completed NCT01168011
Safety, Pharmacokinetics and Clinical Activity of Oral Rigosertib in Solid Tumors treatment 1 completed NCT01165905
Safety of 24-hour Infusion of ON 01910.Na in Combination With Gemcitabine in Advanced Solid Tumors treatment 1 completed NCT01065805
A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma diagnostic 1 / 2 terminated NCT01063075
A Study in Advanced Solid Tumors other 2 completed NCT01049061
A Study of MORAb-003 in Patients With Solid Tumor treatment 1 completed NCT01041235
Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies treatment 1 completed NCT01007422
Opioids Titration in Hospice Patients No drug interventions Not Available Not Available withdrawn NCT01004861
Safety Study of PLX108-01 in Patients With Solid Tumors treatment 1 completed NCT00968916
Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 in Patients With Solid Tumors treatment 1 completed NCT00955812
STAT3 Inhibitor for Solid Tumors No drug interventions treatment 1 completed NCT00927966
RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms treatment 1 completed NCT00920868
XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib treatment 1 completed NCT00920595
Study of CEP-9722 as Single-Agent Therapy and as Combination Therapy With Temozolomide in Patients With Advanced Solid Tumors treatment 1 completed NCT00896662
Analysis of Dendritic Phenotype and Function of Patients Receiving VEGF-Trap on VGFT-ST-0202 No drug interventions Not Available Not Available completed NCT00894049
A Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic Transplantation No drug interventions treatment 2 completed NCT00888108
Safety Profile, MTD, and PK Profile Studies of ABT-263 When Administered in Combination With Standard and Weekly Regimens of Docetaxel in Subjects With Cancer treatment 1 completed NCT00881101
Clinical Study of Liposomal Paclitaxel in Chinese Patients treatment 1 unknown_status NCT00867295
Effectiveness of Antibiotic Prophylaxis for Totally Implantable Venous Access Device treatment 3 completed NCT00847054
A Study of of MORAb-004 in Subjects With Solid Tumors treatment 1 completed NCT00840190
A Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignancies No drug interventions treatment 1 completed NCT00834704
Safety Study of PEGPH20 Given to Patients With Advanced Solid Tumors Not Available 1 completed NCT00803556
Clinical Trial of the Combination of Intravenous Alvespimycin (KOS-1022), Trastuzumab With or Without Paclitaxel in Patients With Advanced Solid Tumor Malignancies or Her2 Positive Metastatic Breast Cancer Who Have Previously Failed Trastuzumab Therapy treatment 1 completed NCT00786669
A Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid Tumors treatment 1 completed NCT00753740
Efficacy Study of Maintenance IT-101 Therapy for Ovarian Cancer Patients. treatment 2 withdrawn NCT00742105
Phase I Study to Determine the Maximum Tolerate Dose (MTD) of BGT226 in Advanced Solid Tumors in Japan No drug interventions treatment 1 terminated NCT00718380
A Phase 1 Study of ABT-869 in Subjects With Solid Tumors treatment 1 completed NCT00704366
AZD0530 Study 21 - Phase I Study in Patients With Solid Tumours treatment 1 completed NCT00697879
Safety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid Tumours treatment 1 completed NCT00689065
Safety Study of CALAA-01 to Treat Solid Tumor Cancers No drug interventions treatment 1 terminated NCT00657176
An Open-Label Phase-1 Study of OPB-31121 in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT00609297
Pain Control in Hospice Patients With Cancer-Related Pain No drug interventions Not Available Not Available completed NCT00544336
Family Quality of Life Among Families With a Member Who is a Cancer Patient No drug interventions Not Available Not Available completed NCT00512798
Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma treatment 1 / 2 terminated NCT00512460
RTA 744 Injection in Patients With Leptomeningeal Disease treatment 1 terminated NCT00483457
Effects of Epidermal Growth Factor Receptor Inhibitor Therapy in the Skin of Cancer Patients No drug interventions Not Available Not Available completed NCT00469937
Ph I Study of Lithium During Whole Brain Radiotherapy For Patients With Brain Metastases supportive_care 1 terminated NCT00470405
Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma treatment 1 completed NCT00424645
Voraxaze for Delayed Methotrexate Clearance supportive_care 1 / 2 terminated NCT00413075
Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma treatment 1 completed NCT00354523
Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma treatment 1 / 2 terminated NCT00300001
Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes No drug interventions Not Available Not Available unknown_status NCT00283257
Simultaneous Care: Linking Palliation to Clinical Trials No drug interventions other Not Available completed NCT00251407
Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor Malignancies treatment 1 completed NCT00215501
Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies treatment 1 completed NCT00052273
LY317615 Plus Capecitabine in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT05219981
18F F-AraG-PET Imaging to Evaluate Immunological Response CKI Therapy in Solid Tumors Imaging No drug interventions diagnostic 2 not_yet_recruiting NCT04545827
Study to Evaluate the Safety of IMM-01 in Patients With Advanced Solid Tumours basic_science 1 not_yet_recruiting NCT03447522
Prospective Collection Tissue Research Protocol No drug interventions Not Available Not Available not_yet_recruiting NCT02318589
Phase I of Eribulin and Oral Irinotecan for Relapsed or Refractory Solid Tumors treatment 1 recruiting NCT01565421
Efficacy Study of Maintenance Therapy for Ovarian Cancer Patients treatment 2 withdrawn NCT01324258
Trial of GSK1120212 and GSK1120212 in Combination With GEM in Japanese Subjects With Solid Tumors treatment 1 completed NCT00972686
Dose-Escalation Study of GSK2126458 treatment 1 completed NCT00687622
Open-label Study to Investigate the Safety, PK, and Pharmacodynamics of GSK1120212 in Subjects With Solid Tumors or Lymphoma treatment 1 completed NCT04529122
A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test No drug interventions Not Available Not Available recruiting NCT01184274
A Phase I Study of SB939 in Pediatric Patients With Refractory Solid Tumours and Leukemia treatment 1 completed NCT00732420
Open-label Study of Topotecan and Pazopanib in Advanced Solid Tumors screening 1 completed NCT01209091
Utility and Work Productivity Data for Economic Evaluation of Breast Cancer Therapies in the Netherlands and Sweden No drug interventions Not Available Not Available completed NCT03572192
Tissue Collection Framework To Improve Outcomes In Solid Tumours No drug interventions Not Available Not Available recruiting NCT00743067
A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally Daily to Subjects With Solid Tumors treatment 1 completed NCT02063204
To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Renal Impaired Subjects and Healthy Subjects basic_science 1 completed NCT01956669
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors treatment 2 completed NCT04236414
Investigating Safety, Tolerability, Efficacy and PK of Olaparib in Paediatric Patients With Solid Tumours treatment 1 recruiting NCT00497679
AZD1152 in Patients With Advanced Solid Malignancies-Study 3 treatment 1 terminated NCT06581432
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations treatment 2 not_yet_recruiting NCT02407509
Phase I Trial of VS-6766 Alone and in Combination With Everolimus treatment 1 recruiting NCT06231277
Phase I Clinical Trial of BH002 in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT02923947
Study to Assess Osimertinib in Patients w/ Adv Solid Tumours & Normal Kidney Function or Severe Kidney Impairment treatment 1 completed NCT02343718
Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours treatment 1 completed NCT04889599
A Bioequivalence Study of Docetaxel Injection in Patients With Solid Tumours other 3 completed NCT04179071
A Study in Healthy Male Subjects to Understand How Savolitinib Behaves Inside the Body (Pharmacokinetics) When Administered Alone and in Combination With Famotidine treatment 1 completed NCT03702036
Compassionate Use Individual Request Program for GSK525762 in NUT Midline Carcinoma Not Available Not Available no_longer_available NCT03415100
Pilot Study of NKG2D-Ligand Targeted CAR-NK Cells in Patients With Metastatic Solid Tumours treatment 1 unknown_status NCT03333824
Effects of AZD1775 on the PK Substrates for CYP3A, CYP2C19, CYP1A2 and on QT Interval in Patients With Advanced Cancer treatment 1 completed NCT03315091
Phase I Study to Assess the Effect of Food on AZD1775 Pharmacokinetics in Patients With Advanced Solid Tumours treatment 1 completed NCT03266159
A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Clinical Activity of GSK525762 Plus Trametinib in Subjects With Solid Tumors treatment 2 withdrawn NCT03150056
Dose Escalation and Dose Expansion Study of GSK525762 in Combination With Androgen Deprivation Therapy in Participants With Castrate-resistant Prostate Cancer treatment 1 terminated NCT02687386
A Study of Intravenous EEDVsMit in Children With Recurrent / Refractory Solid or CNS Tumours Expressing EGFR treatment 1 terminated NCT02492477
TOP-TRIAL Safety of Not Flushing Non-used PORT-A-CATH® in Cancer Patients health_services_research 1 terminated NCT02390986
An Extension Study of LON002 in Patients With Cancer No drug interventions treatment Not Available unknown_status NCT02360345
Phase I Trial of ONX-0801 Once Weekly or Alternate Weekly No drug interventions treatment 1 completed NCT02264418
Safety and Tolerability of ODM-203 in Subjects With Advanced Solid Tumours other 1 completed NCT02263950
A Phase 1/2a Study of LON002 in Subjects With Advanced Solid Tumours treatment 1 / 2 unknown_status NCT02215850
Safety Study of SLC-0111 in Subjects With Advanced Solid Tumours treatment 1 completed NCT02161770
Study to Assess the Blood Levels and Safety of AZD9291 in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment other 1 completed NCT02093728
To Assess the Effect of Itraconazole and Fluconazole on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers basic_science 1 completed NCT02093351
To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer basic_science 1 completed NCT02056392
To Assess the Effects of Single Oral Dose of Selumetinib [AZD6244; ARRY-142886] [Hyd-Sulfate]), on QTc Interval in Healthy Male Volunteers basic_science 1 completed NCT02046850
To Assess the Effect of Rifampicin on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers basic_science 1 completed NCT01998607
Survey of XGEVA® Presrcibers in Europe to Evaluate Their Knowledge of the Summary of Product Characteristics Pertaining to Osteonecrosis of the Jaw No drug interventions Not Available Not Available completed NCT01974349
To Assess the Effect of Food on the Pharmacokinetics of Selumetinib (AZD6244; ARRY-142886) (Hyd-Sulfate) in Healthy Male Volunteers basic_science 1 completed NCT01948297
Debio 1347-101 Phase I Trial in Advanced Solid Tumours With Fibroblast Growth Factor Receptor (FGFR) Alterations treatment 1 terminated NCT01931761
Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C] Selumetinib in Volunteers basic_science 1 completed NCT01928940
Japan PhI/II of GSK2118436 and GSK1120212 Combination in Subjects With BRAF V600E/K Mutation Positive Advanced Solid Tumors (Phase I Part) or Cutaneous Melanoma (Phase II Part) treatment 2 completed NCT01929603
Study to Assess the Effect of Rifampicin (CYP Inducer) on Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours Not Available 1 completed NCT01921140
To Determine the Effect of Food on the Pharmacokinetics of Olaparib and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation in Patients With Advanced Solid Tumours other 1 completed NCT01900028
To Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of Olaparib, and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation to Patients With Advanced Solid Tumours Not Available 1 completed NCT01894243
Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment other 1 completed NCT01894256
Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal or Impaired Kidney Function Not Available 1 completed NCT01851265
D081AC00001 Food Interaction With Olaparib Capsule in Patients With Solid Tumours other 1 completed NCT01767454
Study of Dabrafenib +/- Trametinib in Combination With Ipilimumab for V600E/K Mutation Positive Metastatic or Unresectable Melanoma treatment 1 completed NCT01626547
Biosimilar Retacritâ„¢ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology No drug interventions Not Available Not Available completed NCT01266954
An Open Label Study To Investigate the Pharmacokinetics and Pharmacodynamics of Repeat Escalating Doses of the Oral AKT Inhibitor GSK2141795 by 18F FDG PET Analysis in Subjects With Ovarian Cancer treatment 1 completed NCT00742261
A Bioavailability Study of GSK1363089 in Subjects With Solid Tumors treatment 1 completed NCT00742131
A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally to Subjects With Solid Tumors treatment 1 completed NCT00695448
Phase I Open-Label, Dose-Escalation Study of GSK1059615 in Patients With Solid Tumors or Lymphoma treatment 1 terminated NCT00483860
A Phase I Topotecan Study in Subjects With Cancer and Impaired Renal Function treatment 1 completed NCT00136578
Ispinesib In Combination With Carboplatin In Patients With Solid Tumors treatment 1 completed NCT06488716
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7759065 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT04958226
A Study to Assess the Effect of Capivasertib on Midazolam in Patients With Advanced Solid Tumours treatment 1 completed NCT01489826
A Phase 1 Study of Dexanabinol in Patients With Advanced Solid Tumours treatment 1 completed NCT04121910
A Study to Evaluate the Amount of Drug That Becomes Available in the Blood Circulation When Savolitinib is Administered Alone and in Combination With Itraconazole basic_science 1 completed NCT02648490
An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of HLX07,in Patients With Advanced Solid Cancers treatment 1 completed NCT01627990
Nivestimâ„¢ in Treatment of Malignant Diseases No drug interventions Not Available Not Available completed NCT02086721
Phase I Clinical Study Combining L19-IL2 With SABR in Patients With Oligometastatic Solid Tumor treatment 1 completed NCT06551051
ADC-induced Neurotoxicity Treated with Duloxetine No drug interventions treatment 2 recruiting NCT01447732
Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 completed NCT04891718
CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia basic_science 0 withdrawn NCT01516645
Phase 1 Study of KHK2898 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT01300468
Study of PHA-848125AC in Adult Patients With Advanced/Metastatic Solid Tumors No drug interventions treatment 1 completed NCT01226407
Examine Maximum Tolerated Dose and Pharmacokinetic and Pharmacodynamic Profile treatment 1 unknown_status NCT01219543
A Phase I Study of AZD1480 in Patients With Advanced Solid Malignancies and Advanced Hepatocellular Carcinoma in the Escalation Phase,Non-Small Cell Lung Cancer(NSCLC) and Non-smokers With Lung Metastasis and Gastric Cancer and Solid Tumour in the Expansion Phase. treatment 1 terminated NCT01046461
Ramosetron, Aprepitant and Dexamethasone (RAD) in Solid Cancer prevention 2 unknown_status NCT05543317
68Ga-FAPI-RGD PET/CT for Dual Integrin αvβ3 and FAP-targeted Imaging in Patients With Various Types of Cancer and Compared With 18F-FDG No drug interventions diagnostic Not Available completed NCT05620134
Study of JK08 in Patients With Unresectable Locally Advanced or Metastatic Cancer treatment 1 / 2 recruiting NCT04196530
BDB001-102: Open Label Dose Escalation of BDB001 in Combination w Atezolizumab treatment 1 active_not_recruiting NCT03911557
Durvalumab and Tremelimumab Combination in Somatically Hypermutated Recurrent Solid Tumors treatment 2 active_not_recruiting NCT04717674
[18F]FPIA PET/CT Imaging in Patients With Solid Tumours No drug interventions diagnostic 2 recruiting NCT06347731
Varian ProBeam360° Proton Therapy System China Clinical Trial (Wuhan) No drug interventions treatment Not Available not_yet_recruiting NCT03491631
Phase I Study of SHR9146 + SHR-1210 +/- Apatinib in Patients With Advanced Solid Tumors treatment 1 active_not_recruiting NCT04819373
BDB001-201: A Clinical Study of BDB001 in Patients With PD-(L)1 Refractory Solid Tumors treatment 2 completed NCT04840394
Clinical Study of BDB018: Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors treatment 1 active_not_recruiting NCT04095091
Real-time Tumor Localization and Guidance for Radiotherapy Using Ultrasound (US) and Magnetic Resonance (MR) No drug interventions Not Available Not Available terminated NCT06431529
A Study of Tumor Neoantigen-specific T Cells in the Treatment of Advanced Solid Tumors No drug interventions treatment 0 recruiting NCT05744089
Home Management of Simple Hydromorphone PCA Pump Mode No drug interventions treatment Not Available not_yet_recruiting NCT03486301
BDB001-101: Clinical Study of BDB001 as a Mono-therapy or in Combination With Pembrolizumab treatment 1 active_not_recruiting NCT04750772
Positron Nuclide Labeled DOTA-FAPI PET Study in Colocrectal Cancer No drug interventions diagnostic Not Available unknown_status NCT05108623
A Study Investigating agenT-797 in Participants With Relapsed/Refractory Solid Tumors No drug interventions treatment 1 completed NCT06484790
NW-301 TCR-T in Patients With Advanced Solid Tumor No drug interventions treatment 1 recruiting NCT06175221
Autologous TLPO Vaccine Basket No drug interventions treatment 2 recruiting NCT03276702
Tumor Rebiopsy in Children and Adolescents With Recurrent or Progressive Solid Malignancies No drug interventions Not Available Not Available completed NCT06193902
LEU01101: Safety and Preliminary Efficacy of LEU011 in Solid Tumours. No drug interventions treatment 1 / 2 recruiting NCT05820087
The HistoSonics Edisonâ„¢ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY) No drug interventions treatment Not Available recruiting NCT03454035
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors treatment 1 recruiting NCT05974410
Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients Not Available Not Available available NCT06022029
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. treatment 1 recruiting NCT05221320
Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) Malignancies treatment 2 terminated NCT06484556
NW-301 TCR-T in Patients With Advanced Solid Tumor No drug interventions treatment 1 recruiting NCT04443088
An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors treatment 1 recruiting NCT06478251
NW-301 TCR-T in Patients With Advanced Solid Tumor No drug interventions treatment 1 recruiting NCT05160051
68Ga-FAPI-46 PET for Imaging of FAP Expressing Cancer No drug interventions diagnostic 2 completed NCT06338436
Varian ProBeam Proton Therapy System China Clinical Trial (Guangzhou) No drug interventions treatment Not Available completed NCT06340815
Varian ProBeam Proton Therapy System Clinical Trial (Shandong) No drug interventions treatment Not Available completed NCT04528836
First-in-Human Study of the SHP2 Inhibitor BBP-398 in Patients With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT05432232
The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy No drug interventions treatment Not Available recruiting NCT05943119
Phase II Study of Intensity Modulated Radiotherapy in Dose Painting for Sinus Carcinomas After Endoscopic Surgery No drug interventions treatment 2 recruiting NCT04723810
TumorGlow Intraoperative Molecular Imaging (IMI) diagnostic 1 / 2 not_yet_recruiting NCT05378425
A Study of NTX-1088, a Monoclonal Antibody Targeting the Poliovirus Receptor (PVR, CD155), as Monotherapy and Combined With Pembrolizumab treatment 1 recruiting NCT05661461
Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment treatment 1 recruiting NCT06162988
PET Imaging of 68Ga-NOTA-H006 in Malignancy diagnostic Not Available not_yet_recruiting NCT06126705
18F-AlF-FAPi-04 PET/CT Imaging in Patients With Solid Tumor diagnostic 0 recruiting NCT04788147
Performance and Safety of Biology-Guided Radiotherapy Using the RefleXion Medical Radiotherapy System (BIOGUIDE-X) No drug interventions other Not Available completed NCT05094804
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents treatment 1 / 2 recruiting NCT06090266
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents treatment 1 / 2 recruiting NCT06116032
Immune Profiling for Cancer Immunotherapy Response No drug interventions Not Available Not Available recruiting NCT01358331
A Study of the Safety, Tolerability, and Efficacy of MK-8353 in Participants With Advanced Solid Tumors (MK-8353-001) No drug interventions treatment 1 terminated NCT03731390
GR1405 Injection in Patients With Advanced Solid Tumor or Lymphoma No drug interventions treatment 1 unknown_status NCT03929185
Analysis of Chemical Pattern Exhaled by Different Neoplasms Through Chemoresistive Nanostructured Sensors No drug interventions Not Available Not Available recruiting NCT03985072
Study With Andes-1537 in Patients With Specific Types of Advanced Solid Tumor No drug interventions treatment 1 completed NCT04367948
Positron Nuclide Labeled NOTA-FAPI PET Study in Lymphoma No drug interventions diagnostic Not Available unknown_status NCT04628234
Follow-up of Actual Patient Care Site Two Months After Hospitalisation Compared With Their Expressed Choice Regarding Subsequent Care Site (RESPECT) No drug interventions Not Available Not Available completed NCT04640246
Study of TBX-3400 in Subjects With Solid Malignant Tumors Resistant or Refractory to Standard Therapies treatment 1 / 2 recruiting NCT05346276
PET Imaging of LAG-3 Expression No drug interventions diagnostic Not Available recruiting NCT05637034
68Ga-DOTA-F2 PET/CT in Patients With Various Types of Cancer No drug interventions diagnostic Not Available recruiting NCT05392205
Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer No drug interventions diagnostic Not Available completed NCT05785052
Biomarkers of Renal Cancer No drug interventions Not Available Not Available recruiting NCT04416165
Comparison of FDG and FAPI in Patients With Various Types of Cancer No drug interventions diagnostic Not Available recruiting NCT05082610
A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab treatment 1 recruiting NCT00741234
A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine treatment 1 completed NCT03616834
Tomivosertib (eFT-508) in Combination With PD-1/PD-L1 Inhibitor Therapy treatment 2 completed NCT02660034
The Safety, Pharmacokinetics and Antitumor Activity of BGB-A317 in Combination With BGB-290 in Participants With Advanced Solid Tumors treatment 1 completed NCT00429234
Gemcitabine and Dasatinib in Advanced Solid Tumors treatment 1 completed NCT03554434
An Expanded Access Program for AM0010 (Pegilodecakin) Not Available Not Available no_longer_available NCT01496534
Phase Ib Study of Gemcitabine Plus Cisplatin or Carboplatin Plus Dovitinib in Patients With Advanced Solid Tumors treatment 1 terminated NCT00555724
Phase 1 Study of BIIB022 (Anti-IGF-1R Monoclonal Antibody) in Relapsed/Refractory Solid Tumors No drug interventions treatment 1 completed NCT01222624
PankoMab-GEXâ„¢: Phase 1 Dose Escalation Study treatment 1 completed NCT01002924
Extension Study of EC145 (Vintafolide) for Subjects Enrolled in a Previous Study With EC145 (MK-8109-010) treatment 2 completed NCT03175224
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors treatment 2 recruiting NCT02499224
Safety and Pharmacokinetics Study of YYB101 in Advanced Solid Tumors Patients Who Are Refractory to Standard Therapy No drug interventions treatment 1 completed NCT00618124
A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered Together treatment 1 completed NCT01904916
CPCT-05 Biopsy Protocol Patient Selection No drug interventions other Not Available terminated NCT01215916
A Phase 1 Study in Patients With Solid Tumors treatment 1 completed NCT00582816
Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors No drug interventions treatment 1 / 2 terminated NCT04174716
Basket Trial of IDX-1197, a PARP Inhibitor, in Patients With HRR Mutated Solid Tumors (VASTUS) No drug interventions treatment 1 / 2 active_not_recruiting NCT00688116
Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors treatment 1 unknown_status NCT00974896
QUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid Tumors treatment 1 completed NCT01021358
A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navitoclax). treatment 1 completed NCT01166035
Lenalidomide and Cetuximab in Patients With Advanced Solid Tumors treatment 1 / 2 unknown_status NCT01135563
Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS Tumours treatment 1 completed NCT02556463
A Study of MEDI9197 in Subjects With Solid Tumors or CTCL and in Combination With Durvalumab and/or Palliative Radiation in Subjects With Solid Tumors treatment 1 terminated NCT02705963
A Drug-Drug Interaction Study to Assess the Effect of Trametinib on the Pharmacokinetics of an Oral Contraceptive in Female Patients With Solid Tumors treatment 1 completed NCT02110563
Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma No drug interventions treatment 1 terminated NCT00583063
Interaction Study of Rapamycin and Sunitinib in Patients With Advanced Cancers treatment 0 completed NCT00871663
Phase 1 Weekly Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04629AM6) treatment 1 completed NCT02593786
A Study of Safety, Tolerability and Pharmacokinetics of Nivolumab in Chinese Subjects With Previously Treated Advanced or Recurrent Solid Tumors treatment 1 / 2 completed NCT03641586
The Study of BGB-283 in Chinese Subjects With Local Advanced or Metastatic Malignant Solid Tumor treatment 1 completed NCT02620839
Phase Ib Study of Alpelisib With Cisplatin in Patients With HPV+ Solid Tumor Malignancies treatment 1 terminated NCT01159522
A Dose Escalation Study of SCB01A in Subjects With Advanced Solid Tumors Who Have Failed Standard Therapy treatment 1 completed NCT05059522
Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing treatment 3 active_not_recruiting NCT05238922
Study of INCB123667 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04972422
A Phase 1b Study of ZN-c3 in Chinese Subjects treatment 1 unknown_status NCT03473925
Efficacy and Safety Study of Navarixin (MK-7123) in Combination With Pembrolizumab (MK-3475) in Adults With Selected Advanced/Metastatic Solid Tumors (MK-7123-034) treatment 2 completed NCT00147225
AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin prevention 1 / 2 completed NCT01497925
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer treatment 1 completed NCT02063230
To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Patients With Hepatic Impairment and Healthy Subjects basic_science 1 completed NCT01357330
Oral SAR245408 (XL147) and Oral MSC1936369B in Patients With Locally Advanced or Metastatic Solid Tumors Not Available 1 completed NCT01288430
A Study of DS-2248 in Participants With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT02828930
A Study to Determine the Excretion Balance, Pharmacokinetics, Metabolism and Absolute Oral Bioavailability of a Single Oral Dose of [14C]-Labeled Idasanutlin and an Intravenous Tracer Dose of [13C]-Labeled Idasanutlin in a Single Cohort of Participants With Solid Tumors (Malignancies) treatment 1 completed NCT01008930
Feasibility Study for Imaging of Peripheral Tumors With a High-Resolution PET Imaging System No drug interventions screening Not Available completed NCT04861948
IBI188 Combination Therapy in Solid Tumors treatment 1 terminated NCT00954148
Defining the Utility of PET/CT in the Follow-up of Patients With Solid Tumors No drug interventions diagnostic Not Available terminated NCT00648648
A Dose Escalation Study of Adavosertib (MK-1775) in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001) treatment 1 completed NCT04674748
To Assess the Safety, Tolerability and Pharmacokinetics of INCB086550 treatment 1 terminated NCT03313557
AZD1775 Continued Access Study to Assess Safety and Tolerability for Patients Enrolled in AZD1775 Clinical Pharmacology Studies treatment 1 completed NCT02324257
A Study of RO6958688 in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen Positive Solid Tumors treatment 1 completed NCT06553157
Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy prevention 1 / 2 not_yet_recruiting NCT00887757
Safety Study of ABT-263 in Combination With Gemzar (Gemcitabine) in Subjects With Solid Tumors treatment 1 completed NCT00634257
Spirituality/Religiosity in Patients and Caregivers No drug interventions Not Available Not Available completed NCT02423057
Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors No drug interventions treatment 1 suspended NCT04685226
A Phase I/II Clinical Trial of ICP-723 in the Treatment of Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT00652626
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function other 1 completed NCT05644626
Safety, Pharmacokinetics and Antitumor Activity of BGB-B167 Alone and in Combination With Tislelizumab in Participants With Solid Tumors in Chinese Participants treatment 1 withdrawn NCT01018966
Study of Ixabepilone (BMS-247550) in Patients With Solid Tumors treatment 1 completed NCT02130466
A Study of the Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With Trametinib and Dabrafenib in Participants With Advanced Melanoma (MK-3475-022/KEYNOTE-022) treatment 1 / 2 completed NCT00982865
Trial of MSC1936369B in Subjects With Solid Tumors treatment 1 completed NCT01313065
Evaluation of Safety, Tolerability, PK & PD of Intravenous VX15/2503 in Patients With Advanced Solid Tumors treatment 1 completed NCT04642365
A Study to Evaluate the Safety and Tolerability of RO7296682 in Combination With Atezolizumab in Participants With Advanced Solid Tumors. treatment 1 completed NCT02628574
Phase 1 Open-label Study of TRX518 Monotherapy and TRX518 in Combination With Gemcitabine, Pembrolizumab, or Nivolumab treatment 1 completed NCT02503774
MEDI9447 Alone and in Combination With MEDI4736 in Adult Participants With Select Advanced Solid Tumors. treatment 1 completed NCT02533674
Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM060184 in Combination With Gemcitabine in Selected Patients With Advanced Solid Tumors other 1 completed NCT01149720
Determination of the Relative Bioavailability of ARQ 197 Tablet Formulation With Capsule C Formulation as a Reference in Subjects With Advanced Solid Tumors treatment 1 completed NCT00509782
Phase I Trial of ZIO-101 in Patients With Solid Tumors treatment 1 completed NCT00101582
Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer treatment 3 completed NCT02009631
A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors other 1 completed NCT01994031
Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional Treatments treatment 4 unknown_status NCT01100931
A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II) treatment 1 / 2 completed NCT02157831
Redosing With CP-870, 893 in Patients With Clinical Benefit After a Single Infusion From A Phase I, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid Tumors treatment 0 completed NCT00487331
Acupuncture for Treatment of Uncontrolled Pain: A Feasibility Study No drug interventions supportive_care Not Available completed NCT06410131
Study in Patients With Advanced Solid Tumors to Evaluate the Safety of FTL008.16 No drug interventions treatment 1 not_yet_recruiting NCT03427073
A Phase I Dose-escalation Study of Subcutaneous ALM201 in Patients With Advanced Ovarian Cancer and Other Solid Tumours treatment 1 terminated NCT02350673
A Study of Intravenous (IV) Cergutuzumab Amunaleukin and Atezolizumab in Combination in Participants With Locally Advanced and/or Metastatic Solid Tumors treatment 1 completed NCT02038673
An Open-label Phase I Study of Orally Available Novel Small-molecule Fibroblast Growth Factor Receptors (FGFR) 1,2,3 and 4 Inhibitor, ASP5878 at Single and Multiple Doses in Patients With Solid Tumors No drug interventions treatment 1 completed NCT05774873
IBI334 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT00125827
Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid Tumors treatment 1 completed NCT05149027
A Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combine With Toripalimab in Patients With Advanced HCC and Other Solid Tumors No drug interventions treatment 1 unknown_status NCT02171260
This is a Phase 1 Study of Eribulin Mesylate in Pediatric Participants With Recurrent or Refractory Solid Tumors (Excluding [Central Nervous System] CNS), Including Lymphomas treatment 1 completed NCT01688960
Nesvacumab (REGN910/ SAR307746) and Aflibercept ("Ziv-aflibercept" in the U.S.) in Patients With Advanced Solid Malignancies treatment 1 completed NCT04672460
A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors treatment 1 completed NCT06179160
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation treatment 1 recruiting NCT04009460
A Study of ES101 (PD-L1x4-1BB Bispecific Antibody) in Patients With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT06082960
Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors treatment 1 recruiting NCT05648994
TCR-T Cells for the Treatment NY-ESO-1-positive Advanced Solid Tumors treatment 0 not_yet_recruiting NCT00894894
Safety Study to Determine the Maximum Tolerated Dose, Pharmacokinetics and Pharmacodynamics of Oral MP470, a Multitargeted Tyrosine Kinase Inhibitor, in Patients With Solid Malignancies treatment 1 completed NCT06431594
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Participants With Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT00359294
A Phase I Study of Zalypsis (PM00104) in Subjects With Advanced Malignant Solid Tumors or Lymphoma treatment 1 terminated NCT05524194
6MW3511 in Patients With Advanced Solid Tumor No drug interventions treatment 1 / 2 unknown_status NCT02761694
Vevorisertib (ARQ 751) as a Single Agent or in Combination With Other Anti-Cancer Agents, in Solid Tumors With PIK3CA / AKT / PTEN Mutations (MK-4440-001) treatment 1 terminated NCT03035591
ODM-207 in Patients With Advance Solid Tumours basic_science 1 / 2 completed NCT01125891
Dose Escalation Study of Gemcitabine and ON 01910.Na in Solid Tumors treatment 1 completed NCT02071862
Study of the Glutaminase Inhibitor CB-839 in Solid Tumors treatment 1 completed NCT02508662
Registry Study for Personalized Cancer Therapy No drug interventions Not Available Not Available completed NCT02587962
Dose-escalation Study of Birinapant and Pembrolizumab in Solid Tumors treatment 1 / 2 terminated NCT01251562
Safety Study of Sterile Compound C31510 for Injection to Subjects With Solid Tumors No drug interventions treatment 1 completed NCT02457962
Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study No drug interventions Not Available Not Available recruiting NCT01957280
Study to Assess Pharmacokinetics, Immunogenicity and Safety/Tolerability of Patritumab (U3-1287) treatment 1 completed NCT00832780
Phase II Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Tumors of the Lung No drug interventions treatment Not Available completed NCT05129280
A Study to Evaluate Safety, Pharmacokinetics, and Preliminary Anti-tumor Activity of RO7444973 in Participants With Unresectable and/or Metastatic MAGE-A4-positive Solid Tumors treatment 1 terminated NCT01702129
Anti-EGFR Immunoliposomes in Solid Tumors treatment 1 completed NCT03745989
Study of MK-8353 + Selumetinib in Advanced/Metastatic Solid Tumors (MK-8353-014) treatment 1 completed NCT01556789
Phase 1 Study of ONT-10 in Patients With Solid Tumors No drug interventions treatment 1 completed NCT00591292
Phase I Study in Advanced Solid Tumors treatment 1 unknown_status NCT02052492
Safety Study of EF-022 ( Modified Vitamin D Binding Protein Macrophage Activator) in Subjects With Advanced Solid Tumors treatment 1 completed NCT04613492
A Study of MEDI9253 in Combination With Durvalumab in Select Solid Tumors treatment 1 completed NCT00502892
Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors treatment 1 completed NCT04627740
Anti-ALPP CAR-T Cells Immunotherapy for Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT00125840
Clofarabine in Adult Patients With Advanced Solid Tumors Not Available 1 completed NCT00426140
Pharmacokinetics of Patupilone After a Single Intravenous Administration in Patients With Advance Solid Tumor Malignancies. treatment 1 completed NCT01286467
A Study Of PF-04449913 Administered Alone In Select Solid Tumors treatment 1 completed NCT03954067
A Study of an Intratumoral Oncolytic Virus in Patients With Advanced Metastatic Solid Tumors treatment 1 completed NCT05372367
A Study in People With Advanced Cancer to Test Whether the Amount of BI 907828 in the Blood is Influenced by Taking an OATP Inhibitor or a CYP3 Inhibitor treatment 1 active_not_recruiting NCT02650401
Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options treatment 1 / 2 active_not_recruiting NCT01226901
A Phase I Study of MK-4827 for Treatment of Solid Tumors (MK-4827-005) treatment 1 terminated NCT01940601
Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors treatment 2 withdrawn NCT01875601
NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors treatment 1 completed NCT04939701
Study of ASP0739 Alone and With Pembrolizumab in Advanced Solid Tumors With NY-ESO-1 Expression Participants No drug interventions treatment 1 / 2 terminated NCT03444701
A Study of E7130 in Participants With Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT00425204
Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment treatment 2 completed NCT00754104
Study of ABT-869 in Combination With Tarceva in Subjects With Solid Tumors treatment 1 withdrawn NCT02718404
3 Tesla Magnetic Resonance Guided High Intensity Focused Ultrasound in the Treatment of Pain From Bone Metastases of Solid Tumors No drug interventions treatment Not Available terminated NCT05203172
The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials treatment 4 recruiting NCT03934372
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors treatment 1 / 2 recruiting NCT01271972
Study of Nesvacumab (REGN910/ SAR307746) treatment 1 completed NCT00495872
Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor treatment 1 completed NCT00944372
Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent Tumors diagnostic 4 terminated NCT01214668
Dose-Escalation Study of LY573636-sodium and Liposomal Doxorubicin in Patients With Advanced Solid Tumors treatment 1 completed NCT00554268
Trial of PBI-05204 in Advanced Cancer Patients No drug interventions treatment 1 completed NCT01851369
TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas treatment 1 / 2 completed NCT03832569
Study of Pembrolizumab Following Surgery in Patients With Microsatellite Instability High (MSI-H) Solid Tumors treatment 0 active_not_recruiting NCT02216669
Trial to Determine Optimal Phase II Dose of the Oral Dual CAIX Inhibitor/ Radiosensitizer treatment 1 withdrawn NCT02639546
Safety and Pharmacokinetics of Cobimetinib in Pediatric and Young Adult Participants With Previously Treated Solid Tumors treatment 1 / 2 completed NCT02366546
Investigator Initiated Phase 1 Study of TBI-1301 treatment 1 unknown_status NCT06553846
A Clinial Trial of Lutetium [177Lu]-FAP-75 for the Treatment of Patients With Advanced Solid Tumors treatment 1 not_yet_recruiting NCT01222546
Study of CH5132799 Administered Orally in Patients With Advanced Solid Tumors treatment 1 completed NCT01277146
A Dose Escalation Study of OMP-59R5 in Subjects With Solid Tumors treatment 1 completed NCT02354612
Open Label Continuation Study of TRC105 for Patients Who Have Completed a Prior TRC105 Trial Not Available Not Available no_longer_available NCT01809912
Safety Study of MG1102 in Patients With Solid Tumors No drug interventions treatment 1 terminated NCT00551512
Phase I Study of CBP501 and Cisplatin in Patients With Advanced Refractory Solid Tumors treatment 1 completed NCT00634010
Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain treatment 3 terminated NCT02265510
An Open-Label Study of a Novel JAK-inhibitor, INCB052793, Given to Patients With Advanced Malignancies treatment 1 / 2 terminated NCT01945710
An Open-label, Multicenter, Multiple Dose, Phase 1 Study to Establish the Maximum Tolerated Dose of E7389 Liposomal Formulation in Patients With Solid Tumors treatment 1 completed NCT02034981
Phase 2 Study Assessing Efficacy and Safety of Crizotinib in Patients Harboring an Alteration on ALK, MET or ROS1 treatment 2 completed NCT02746081
Phase I Study of BAY1436032 in IDH1-mutant Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT02683395
A Study of PLX51107 in Advanced Malignancies treatment 1 terminated NCT02680795
Establish the PK of Belinostat in Patients With Wild-type, Heterozygous, and Homozygous UGT1A1*28 Genotypes treatment 1 completed NCT02797795
A Phase 1, Open-Label, Dose-Escalation Study of NEV801, Administered to Patients With Advanced Cancers No drug interventions treatment 1 unknown_status NCT00606814
Phase I Study of IPI-504 and Docetaxel in Patients With Advanced Solid Tumors treatment 1 completed NCT01375114
The Effects of Ginseng on Cancer-Related Fatigue treatment 2 active_not_recruiting NCT04465214
Mobile Sensor Technologies to Assess General Symptomology of People With Cancer No drug interventions Not Available Not Available enrolling_by_invitation NCT02262455
Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors treatment 1 completed NCT02476955
Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole treatment 1 terminated NCT02674555
A Study to Investigate the Absorption, Metabolism and Excretion of [14C]ASP8273 in Subjects With Solid Tumors treatment 1 withdrawn NCT02503423
Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas treatment 1 / 2 active_not_recruiting NCT02700308
A Study of Kyphoplasty and Vertebroplasty in the Treatment of Spine Metastases No drug interventions treatment 2 terminated NCT01081808
Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid Tumors No drug interventions treatment 1 terminated NCT03252938
Feasibility and Safety of IMP321 (Eftilagimod Alpha) for Advanced Stage Solid Tumors treatment 1 recruiting NCT02881138
A Study of RC48-ADC in Subjects With HER2-Positive Advanced Malignant Solid Tumors No drug interventions treatment 1 completed NCT01461538
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies treatment 2 completed NCT01999738
Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors treatment 1 completed NCT00586443
BEP Study Phase I (Bevacizumab, Everolimus, Panitumumab) Not Available 1 completed NCT01409343
TrasGEXâ„¢: Phase 1 Study in Cancer Patients No drug interventions treatment 1 completed NCT03926143
A Clinical Study of Anetumab Ravtansine in Adults With Solid Tumors Who Have Been Treated in Previous Bayer-sponsored Anetumab Ravtansine Studies treatment 2 terminated NCT00888043
Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors Not Available 1 completed NCT03815643
Avelumab Program Rollover Study treatment 3 active_not_recruiting NCT01803503
Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors treatment 2 unknown_status NCT00741403
A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies treatment 1 completed NCT03724890
Study of Avelumab-M3814 Combinations treatment 1 completed NCT01978964
Phase 1b Maintenance Therapy Study of ONT-10 in Patients With Solid Tumors No drug interventions treatment 1 completed NCT00937664
Safety and Tolerability Study of AZD7762 in Combination With Gemcitabine treatment 1 terminated NCT02171221
Phase I Study of Oral DFP-11207 in Solid Tumors No drug interventions treatment 1 completed NCT00585221
Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) Patients treatment 2 terminated NCT00404521
A Phase I Study of PM02734 in Subjects With Advanced Malignant Solid Tumors treatment 1 terminated NCT00391521
AS703569 Phase I in Patients With Solid Tumours treatment 1 completed NCT00697502
Study of Capecitabine In Patients With Solid Tumors treatment 1 completed NCT05225584
Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors treatment 1 recruiting NCT00635284
ABI-009 Trial in Patients With Advanced Non-hematologic Malignancies treatment 1 completed NCT01603979
A Phase 1 Dose Escalation Study of AV-203, an ERBB3 Inhibitory Antibody, in Subjects With Advanced Solid Tumors No drug interventions treatment 1 completed NCT01259479
Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors treatment 1 completed NCT00186979
Study of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients With Refractory Solid Tumors treatment 1 completed NCT06390995
A Study of TAK-853 in Adult Participants With Folate Receptor Alpha-Positive Advanced Ovarian Cancer And Other Solid Tumors treatment 1 / 2 recruiting NCT00777582
Phase I Comparative Bioavailability Study basic_science 1 active_not_recruiting NCT03448042
A Study of Runimotamab in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers treatment 1 active_not_recruiting NCT03917381
GEN1046 Safety Trial in Patients With Malignant Solid Tumors treatment 1 / 2 active_not_recruiting NCT04140500
Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors treatment 1 / 2 recruiting NCT04303858
A Study to Evaluate Safety and Anti-Tumor Activity of Eciskafusp Alfa (RO7284755) Alone or in Combination With Atezolizumab in Participants With Advanced and/or Metastatic Solid Tumors treatment 1 active_not_recruiting NCT05325866
A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression treatment 1 / 2 recruiting NCT02315599
Follow-Up Evaluation for Gene-Therapy-Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials No drug interventions Not Available Not Available enrolling_by_invitation NCT03486873
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587) treatment 3 recruiting NCT03708328
A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors treatment 1 completed NCT04250155
An Open-Label Dose-Escalation Study to Evaluate XmAb24306 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT04589845
Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study treatment 2 recruiting NCT06331598
A Study of Adjuvant Atezolizumab or Atezolizumab Plus Tiragolumab in Solid Tumors With Resectable Disease With Intermediate-High Risk of Recurrence and High Tumor Mutational Burden (TMB-H) or Microsatellite Instability (MSI-H) treatment 2 recruiting NCT00791154
QUILT-2.013: First-Line Treatment for Extensive Stage Small Cell Lung Cancer treatment 1 / 2 terminated NCT00819169
QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors treatment 1 / 2 terminated NCT00909025
Safety and Tolerability Study of Claudiximab in Patients With Advanced Gastroesophageal Cancer No drug interventions other 1 completed NCT01197885
Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer treatment 2 completed NCT02379416
Combination Nilotinib and Paclitaxel in Adults With Relapsed Solid Tumors treatment 1 recruiting NCT05024214
Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors treatment 1 / 2 recruiting NCT05419375
Screening Study for Participants With Malignant Tumors No drug interventions other 2 recruiting NCT05600933
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment No drug interventions Not Available Not Available enrolling_by_invitation NCT05996445
A Study of XmAb®662 as Monotherapy or in Combination With Pembrolizumab in Advanced Solid Tumors treatment 1 terminated NCT06224387
CTS2190 Phase I /II Clinical Study in Patients No drug interventions treatment 1 / 2 recruiting NCT06345001
A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer or Other Select Solid Cancers No drug interventions other 1 not_yet_recruiting NCT03313778
Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors treatment 1 recruiting NCT03366116
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04442425
Machine Learning to Analyze Facial Imaging, Voice and Spoken Language for the Capture and Classification of Cancer/Tumor Pain No drug interventions Not Available Not Available completed NCT05155332
A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors) No drug interventions treatment 1 recruiting NCT06049212
Sacituzumab Tirumotecan (MK-2870) as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-2870-008) treatment 1 recruiting NCT01445509
Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors treatment 1 completed NCT02240238
Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer treatment 1 / 2 completed NCT03709680
Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors treatment 1 / 2 active_not_recruiting NCT05976334
An Absorption, Distribution, Metabolism, Excretion (ADME) Study of [14C]Subasumstat in Adults With Advanced or Metastatic Solid Tumors treatment 1 terminated NCT06036121
A Study of ADRX-0706 in Select Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06386146
JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation No drug interventions treatment 1 / 2 recruiting NCT06536400
Phase I Study of HSK42360 in Solid Tumors With BRAF V600 Mutation No drug interventions treatment 1 recruiting NCT02498912
Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors treatment 1 active_not_recruiting NCT04405778
A Study of TAK-102 in Adult With Previously-Treated Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT01283945
Study of Oral Lucitanib (E-3810), a Dual VEGFR-FGFR Tyrosine Kinase Inhibitor, in Patients With Solid Tumors treatment 1 / 2 completed NCT01855477
CPCT-02 Biopsy Protocol No drug interventions other Not Available completed NCT02091141
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors treatment 2 completed NCT04704154
A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors treatment 2 completed NCT05262400
A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors treatment 1 / 2 recruiting NCT05327946
A Study in People With Advanced Cancer to Test How Well Different Doses of BI 770371 Alone or in Combination With Ezabenlimab Are Tolerated treatment 1 active_not_recruiting NCT05536141
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors treatment 1 recruiting NCT05836324
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT06205706
BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors treatment 1 / 2 recruiting NCT01231347
QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas treatment 3 completed NCT05668585
A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors treatment 1 / 2 recruiting NCT03301896
Study of the Safety and Efficacy of LHC165 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies treatment 1 terminated NCT05387265
A Trial to Find Safe and Active Doses for an Investigational Drug, CX-904, for Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06158958
A Study to Assess the Safety, Pharmacokinetics, and Efficacy of Intravenous (IV) ABBV-303, as Monotherapy and in Combination With IV Infused Budigalimab (ABBV-181), in Adults With Advanced Solid Tumors treatment 1 recruiting NCT05512377
Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder treatment 2 recruiting NCT05731947
Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors treatment 1 / 2 recruiting NCT00489307
Dexamethasone for Symptom Burden in Advanced Cancer Patients treatment 2 active_not_recruiting NCT04574583
Phase I/II Trial Investigating the Safety, Tolerability, Pharmacokinetics, Immune and Clinical Activity of SX-682 in Combination With BinTrafusp Alfa (M7824 or TGF-beta "Trap"/PD-L1) With CV301 TRICOM in Advanced Solid Tumors (STAT) treatment 1 / 2 completed NCT05839600
A Study to Find a Suitable Dose of BI 1821736 and Test Whether it Helps People With Advanced Cancer No drug interventions treatment 1 recruiting NCT06233292
A Study of ZG005 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT06281678
A Study of IBI363 in Subjects With Advanced Solid Malignancies No drug interventions treatment 2 recruiting NCT02154022
Collection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future Toxicity No drug interventions Not Available Not Available enrolling_by_invitation NCT02304809
Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations treatment 2 active_not_recruiting NCT02834611
Ceramide NanoLiposome in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT02667873
A Phase 1 Trial of a Novel XPO1 Inhibitor in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT04337177
Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors treatment 1 recruiting NCT05613036
A Study in People With Advanced Cancer to Test How BI 907828 is Processed in the Body treatment 1 active_not_recruiting NCT06227377
QTX3034 in Patients With KRAS G12D Mutation treatment 1 recruiting NCT04570423
A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy treatment 2 recruiting NCT06418061
Study of IBI3005 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT03813615
Study of the Effects of Pre-surgical Aerobic Exercise on Patients With Solid Tumors No drug interventions treatment 0 active_not_recruiting NCT05315700
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration treatment 1 / 2 recruiting NCT02517398
MSB0011359C (M7824) in Metastatic or Locally Advanced Solid Tumors treatment 1 completed NCT00940225
Study of Cabozantinib (XL184) in Adults With Advanced Malignancies treatment 2 completed NCT03715933
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas treatment 1 recruiting NCT04730843
A Study of ES102 (OX40 Agonist) in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT05650242
A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1106 in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT00750841
Study of the Effect of Rifampicin on the Pharmacokinetics (PK) of Multiple Doses of Cediranib in Patients With Solid Tumours treatment 1 active_not_recruiting NCT02632448
A Study of LY2880070 in Participants With Advanced or Metastatic Cancer basic_science 1 / 2 recruiting NCT04029688
A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in Treatment of Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias or Solid Tumors treatment 1 / 2 active_not_recruiting NCT05101070
S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors treatment 1 / 2 recruiting NCT02022982
PALBOCICLIB + PD-0325901 for NSCLC & Solid Tumors treatment 1 completed NCT02140736
Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and Oncology No drug interventions Not Available Not Available completed NCT03010176
Study of Ulevostinag (MK-1454) Alone or in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors or Lymphomas (MK-1454-001) treatment 1 completed NCT03477175
Study to Assess the Long-term Safety of Lenvatinib Monotherapy, a Lenvatinib Combination Regimen, or a Comparator Treatment Arm to Cancer Participants in Eisai Sponsored Lenvatinib Trials treatment 2 completed NCT04158583
A Study to Evaluate the Safety and Tolerability of RO7296682 in Participants With Advanced Solid Tumors treatment 1 terminated NCT06298773
Spatial Profile of Tumors No drug interventions Not Available Not Available not_yet_recruiting NCT01166009
CIBMTR Research Database No drug interventions Not Available Not Available recruiting NCT04774952
Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT06066424
Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA) treatment 1 recruiting NCT03065062
Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors treatment 1 recruiting NCT03744819
Biomarkers for Prediction of Tumor Response to Radiotherapy No drug interventions Not Available Not Available recruiting NCT04857138
A Study to Evaluate Safety, Pharmacokinetics and Anti-Tumor Activity of RO7300490, as Single Agent or in Combination With Atezolizumab in Participants With Advanced Solid Tumors treatment 1 completed NCT01311713
Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Participants With Solid Tumors treatment 1 / 2 terminated NCT03255070
A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01) treatment 1 completed NCT04418167
JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations treatment 1 suspended NCT02009449
A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors treatment 1 active_not_recruiting NCT06001684
Phase 1 Study of IBR854 in Locally Advanced Or Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT05164666
A Study of TAK-103 in Adult With Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT04123366
Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (MK-7339-007/KEYLYNK-007) treatment 2 active_not_recruiting NCT05471856
A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours) treatment 1 recruiting NCT03314935
A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors treatment 1 / 2 completed NCT06163053
A Study to Evaluate Satisfaction With Care in Patients With Cancer Receiving Immunotherapy Treatment at Home No drug interventions Not Available Not Available recruiting NCT01190644
Study to Evaluate Effect of a Single Dose of Sotatercept (ACE-011) on Red Blood Cell Mass and Plasma Volume in Participants With Solid Tumors supportive_care 2 terminated NCT03762447
A Study Exploring the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB086550 in Participants With Advanced Solid Tumors treatment 1 completed NCT03861403
A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors treatment 1 terminated NCT04190823
A Study of RC98 in Subjects With Advanced Malignant Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT00900497
A Study Using White Blood Cells From Healthy Donors To Treat Solid Cancers No drug interventions treatment 1 / 2 enrolling_by_invitation NCT03225105
M3541 in Combination With Radiotherapy in Solid Tumors No drug interventions treatment 1 terminated NCT01775072
Genomic Profiling in Cancer Patients No drug interventions Not Available Not Available recruiting NCT02521844
A Study to Evaluate the Safety and Tolerability of ETC-1922159 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumours treatment 1 active_not_recruiting NCT03946800
A Study of MEDI1191 in Sequential and Concurrent Combination With Durvalumab in Subjects With Advanced Solid Tumors treatment 1 completed NCT05905341
Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors. treatment 1 withdrawn NCT00828919
Continuing Access to Axitinib (A406- AG- 013736 ) For Patients Previously Receiving AG 013736 In Clinical Trials treatment Not Available completed NCT01047007
A Dose Escalation Study of Adavosertib(MK1775) in Combination With 5-FU or 5-FU/CDDP in Patients With Advanced Solid Tumor (1775-005 treatment 1 terminated NCT02789228
Research Study Utilizing Expanded Multi-antigen Specific Lymphocytes for the Treatment of Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT03030417
Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas No drug interventions treatment 1 completed NCT03690154
A Phase 1 Study to Evaluate FN-1501 Monotherapy in Patients With Advanced Solid Tumors and R/R AML treatment 1 terminated NCT04237649
KAZ954 Alone and With PDR001, NZV930 and NIR178 in Advanced Solid Tumors treatment 0 terminated NCT04714086
Expanded Access Program for Avapritinib Not Available Not Available available NCT05012397
Milademetan in Advanced/Metastatic Solid Tumors treatment 2 terminated NCT06011291
A Study of SYH2051 Monotherapy in Advanced Solid Tumors or in Combination With Radiotherapy in Locally Advanced Head and Neck Cancer No drug interventions treatment 1 recruiting NCT02536183
A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors treatment 1 terminated NCT02277717
First-in-human Study With the Antibody-drug Conjugate SYD985 to Evaluate Safety and Efficacy in Cancer Patients treatment 1 completed NCT04791228
A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors treatment 2 recruiting NCT02506517
A Study of Afatinib in Patients With Advanced Cancer With Changes in the HER Gene treatment 2 completed NCT02988817
Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors treatment 1 / 2 completed NCT01430572
Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients treatment 1 completed NCT05904457
A Phase II Stydy of Bevacizumab Plus Erlotinib in Patients for Krebs Cycle Altered Cancer treatment 2 recruiting NCT05877651
MASCT-I in Patients With Metastatic or Recurrent Solid Tumors Who Failed Standard Therapy. No drug interventions treatment 1 completed NCT04341259
A Study Of The Pharmacokinetics And Safety Of Ipatasertib In Chinese Participants With Locally Advanced Or Metastatic Solid Tumors. treatment 1 completed NCT02426892
Nivolumab and HPV-16 Vaccination in Patients With HPV-16 Positive Incurable Solid Tumors treatment 2 completed NCT02942095
Study of Ixazomib and Erlotinib in Solid Tumors treatment 1 completed NCT04423029
A Study of DF6002 Alone and in Combination With Nivolumab treatment 1 / 2 recruiting NCT02890368
Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides treatment 1 terminated NCT01570296
A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR treatment 1 completed NCT02598960
An Investigational Immuno-therapy Study of Experimental Medication BMS-986156, Given by Itself or in Combination With Nivolumab in Patients With Solid Cancers or Cancers That Have Spread. treatment 1 / 2 completed NCT05419817
Pembrolizumab With Sitravatinib in Recurrent Endometrial Cancer and Other Solid Tumors With Deficient Mismatch Repair System treatment 2 withdrawn NCT02903914
Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors treatment 1 / 2 completed NCT05740215
Efficacy and Safety Study of F520 Combined With Lenvatinib in the Treatment of Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT01379287
Dose-Escalation Safety and Pharmacokinetic Study of Iso-Fludelone in Patients With Advanced Solid Tumors treatment 1 completed NCT01528046
Metformin in Children With Relapsed or Refractory Solid Tumors treatment 1 completed NCT02702492
PAK4 and NAMPT in Patients With Solid Malignancies or NHL (PANAMA) treatment 1 terminated NCT05490472
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05522582
Methotrexate Combined With Immunotherapy During Radiotherapy for Solid Tumors treatment 2 recruiting NCT05416749
A Clinical Study of 8MW2311 in Subjects With Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05231733
Study of SPX-101 in Subjects With Advanced or Refractory Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT05216965
A Clinical Study of 9MW2821 in Subjects With Advanced Malignant Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05167370
High Dose Chemotherapy With Amifostine and Autologous Stem Cell Transplantation for High Risk Relapsed Pediatric Solid Tumors and Brain Tumors treatment 2 terminated NCT05167071
HBM4003 Combine With Toripalimab in Patients With Advanced NEN and Other Solid Tumors Study treatment 1 not_yet_recruiting NCT05107193
Afatinib (GILOTRIF®) in Patients Suffering From Tumors Harboring Neuregulin 1 (NRG1) Gene Alterations (Specifically NRG1 Gene Fusion-positive Advanced Solid Tumors) Not Available Not Available no_longer_available NCT04937842
Microtransplantation for Advanced and Relapsed Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT04727164
Study Investigating Safety,Tolerability,Pharmacokinetics and Antitumor Activities of HBM4003 Combine With Toripalimab No drug interventions treatment 1 not_yet_recruiting NCT04653142
A Study to Test Different Doses of BI 765063 Alone and in Combination With BI 754091 in Japanese Patients With Different Types of Advanced Cancer (Solid Tumors) treatment 1 completed NCT04260009
Pharmacokinetics, Safety, and Efficacy of Brigatinib Monotherapy in Pediatric and Young Adult Participants With ALK+ Anaplastic Large Cell Lymphoma, Inflammatory Myofibroblastic Tumors or Other Solid Tumors treatment 1 / 2 withdrawn NCT04187456
A Study in Healthy Male Subjects to Understand How Savolitinib When Taken With Midazolam Behaves Inside the Body treatment 1 completed NCT04118842
A Study in Healthy Subjects to Assess the Pharmacokinetics of Savolitinib When Administered Alone and in Combination With Rifampicin basic_science 1 completed NCT03998345
Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A in China No drug interventions treatment Not Available unknown_status NCT03965845
A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid Tumors treatment 1 / 2 completed NCT03950297
Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A No drug interventions treatment 1 unknown_status NCT03634982
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT03539484
A Study of RO7172508 in Patients With Locally Advanced and/or Metastatic CEA-Positive Solid Tumors treatment 1 terminated NCT03503604
A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors treatment 1 unknown_status NCT03386942
A Study of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin) in Participants With Solid Tumors treatment 1 completed NCT03362723
A Study to Investigate the Bioequivalence or Relative Bioavailability of Three New Idasanutlin Tablet Variants Following Oral Administration in Participants With Solid Tumors treatment 1 completed NCT03361228
A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid Tumors treatment 1 / 2 terminated NCT03347318
Target Therapies Resistance Molecular Profiling in Patients With Neoplastic Disease No drug interventions Not Available Not Available unknown_status NCT03347123
A Study of Epacadostat and Nivolumab in Combination With Immune Therapies in Participants With Advanced or Metastatic Malignancies (ECHO-208) treatment 1 / 2 terminated NCT03264066
A Study to Investigate the Efficacy and Safety of Cobimetinib Plus Atezolizumab in Participants With Solid Tumors treatment 2 completed NCT03258515
A Study to Investigate the Effect of Single Dose of AZD6094 (600 mg) on Cardiac Repolarization in Healthy Volunteers treatment 1 completed NCT03258151
Association of Genetic Polymorphisms With Docetaxel-based Chemotherapy Toxicities in Chinese Solid Tumor Patients No drug interventions Not Available Not Available unknown_status NCT03235570
A Safety and Tolerability Study of Pemigatinib in Japanese Subjects With Advanced Malignancies - (FIGHT-102) treatment 1 completed NCT03144661
An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies No drug interventions treatment 1 terminated NCT03101488
Phase I Study of KN035 in Chinese Subjects With Advanced Solid Tumors treatment 1 completed NCT03076372
A Study Evaluating MM-310 in Patients With Solid Tumors No drug interventions treatment 1 unknown_status NCT03006887
Phase 1b Trial of Lenvatinib Plus Pembrolizumab in Participants With Selected Solid Tumors treatment 1 completed NCT03006029
Dose Escalation Study of TAB08 in Patients With Advanced Solid Neoplasms other 1 completed NCT02959437
Azacitidine Combined With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors (ECHO-206) treatment 1 / 2 terminated NCT02916095
Kanitinib in Treating Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT02909452
Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors treatment 1 completed NCT02897778
Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors treatment 1 completed NCT02881190
Study of RC48-ADC Administered Intravenously to Subjects With HER2-Positive in Advanced Malignant Solid Tumors No drug interventions treatment 1 completed NCT02858232
MASCT-I Treatment for Advanced Solid Tumor supportive_care 1 / 2 unknown_status NCT02857166
Study of JS001 in Participants With Advanced Solid Tumors treatment 1 completed NCT02857699
Prospective Observational Study to Investigate the Added Value of the Health Related Quality of Life and Patient Reported Symptoms in the Identification of the Recommended Phase II Dose in Phase I Trials of Molecularly Targeted Therapies. No drug interventions Not Available Not Available unknown_status NCT02845414
Study of CD133KDEL Toxin in the Treatment for Solid Tumors No drug interventions treatment 1 withdrawn NCT02827968
Phase 1 Study of Anti-PD-L1 Monoclonal Antibody KN035 to Treat Locally Advanced or Metastatic Solid Tumors treatment 1 completed NCT02766842
Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore) No drug interventions diagnostic 2 withdrawn NCT02762981
Study to Evaluate Relacorilant (CORT125134) in Combination With Nab-paclitaxel in Participants With Solid Tumors treatment 1 / 2 completed NCT02759640
A Phase I Trial of HS-10241 in Solid Tumors No drug interventions treatment 1 completed NCT02759666
A Phase I Trial of SHR3162 in Subjects With Advanced Solid Tumors treatment 1 completed NCT02748837
A Study of ERY974 in Patient With Advanced Solid Tumors No drug interventions treatment 1 completed NCT02740270
Phase I/Ib Study of GWN323 Alone and in Combination With PDR001 in Patients With Advanced Malignancies and Lymphomas treatment 1 completed NCT02721043
Safety and Immunogenicity of Personalized Genomic Vaccine to Treat Malignancies treatment 1 completed NCT02719691
Phase I Study of MLN0128 and MLN8237 in Patients With Advanced Solid Tumors and Metastatic Triple-negative Breast Cancer treatment 1 completed NCT02711137
Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies treatment 1 / 2 terminated NCT02702583
The Oral Cavity as a Source of Febrile Neutropenia No drug interventions Not Available Not Available completed NCT02699515
MSB0011359C (M7824) in Subjects With Metastatic or Locally Advanced Solid Tumors treatment 1 completed NCT02678754
Caris Molecular Intelligence Registry No drug interventions Not Available Not Available terminated NCT02675946
CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596) treatment 1 recruiting NCT02673736
A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor No drug interventions treatment 1 terminated NCT02661542
Study of FF-10502-01 in Patients With Advanced Solid Tumors and Lymphomas treatment 1 / 2 completed NCT02660281
URMC Related Haplo-identical Donor BMT treatment 1 completed NCT02650713
A Study of the Safety, Pharmacokinetics, and Therapeutic Activity of RO6958688 in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen (CEA)-Positive Solid Tumors treatment 1 completed NCT02648711
Alternative Dosing for CRLX101(NLG207) Alone, With Avastin and With mFOLFOX6 in Advanced Solid Tumors treatment 1 terminated NCT02646748
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors treatment 1 completed NCT02630368
A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX) treatment 1 / 2 recruiting NCT02619045
Evaluation of the Impact of a Follow-up Phone Call Nurse Device in the Care of Patients With Chemotherapy Treatment No drug interventions health_services_research Not Available completed NCT02610361
Study of the Safety and Pharmacokinetics of BGB-283 in Patients With Solid Tumors treatment 1 completed NCT02608125
A Dose Escalation Study in Solid Tumors and a Dose Expansion Study of PRN1371 in Adult Patients With Metastatic Urothelial Carcinoma No drug interventions treatment 1 terminated NCT02597036
A Study of LY3127804 With Ramucirumab in Participants With Advanced Solid Tumors treatment 1 completed NCT02587598
Study of INCB053914 in Subjects With Advanced Malignancies treatment 1 / 2 terminated NCT02559492
Itacitinib Combined With INCB024360 and/or Itacitinib Combined With INCB050465 in Advanced Solid Tumors treatment 1 terminated NCT02546531
Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer treatment 1 completed NCT02537561
Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors treatment 1 withdrawn NCT02500199
Phase I Study of Pyrotinib in Patients With HER2-positive Solid Tumors treatment 1 active_not_recruiting NCT02496949
A Phase Ib Study to Assess Safety and Efficacy of Oral Icaritin in Advanced Solid Tumors treatment 1 completed NCT02478866
Safety and Pharmacokinetics of BPI-9016M in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT02451007
Evaluation of the Effect of Lurbinectedin (PM01183) on Cardiac Repolarization in Patients With Selected Solid Tumors other 2 completed NCT02442531
A Study of CriPec® Docetaxel Given to Patients With Solid Tumours treatment 1 completed NCT02439489
Study of the Combination of BKM120 and Cisplatin or Carboplatin in Patients With Advanced Solid Tumors treatment 1 completed NCT02435927
ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin treatment 1 active_not_recruiting NCT02395068
Pharmacokinetics Study of Nimotuzumab in Patients With Solid Tumors treatment 1 unknown_status NCT02379741
ADC-1013 First-in-Human Study treatment 1 completed NCT02368106
Prospective Patient Registry for Radiation Oncology Techniques and Quality No drug interventions Not Available Not Available withdrawn NCT02353026
Phase I Study of Intravenous Artesunate for Solid Tumors treatment 1 completed NCT02318277
A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors (ECHO-203) treatment 1 / 2 completed NCT02307240
Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors treatment 1 completed NCT02304393
A Study of Selicrelumab (RO7009789) in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Solid Tumors treatment 1 completed NCT02303028
Phase I Dose Escalation Study of Topotecan and Pazopanib in Children With Recurrent/Refractory Solid Tumours treatment 1 / 2 completed NCT02301754
INVAC-1 Anti-Cancer hTERT DNA Immunotherapy treatment 1 completed NCT02296879
A Multicenter, Open Label, Phase I Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenous SAIT301 in Subjects With Advanced c-MET Positive (+) Solid Tumors Followed by Expansion in Selected Tumor Types No drug interventions treatment 1 completed NCT02279433
A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b treatment 1 completed NCT02250781
Oral ONC201 in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT02213822
Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic Analysis No drug interventions Not Available Not Available unknown_status NCT02178722
Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers treatment 1 / 2 completed NCT02135510
MEtoclopramide, DExamethasone or Axoli to Prevent or Delay Chemotherapy-induced Nausea and Vomiting in Moderately Emetogenic Non-AC-based Chemotherapy treatment 3 completed NCT02122809
Phase I Study of Chiauranib in Patients With Advanced Solid Tumors treatment 1 completed NCT02120118
Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) in Treatment Failure Solid Tumors treatment 2 withdrawn NCT02116803
An Open Label Multi-center Extension Study to Evaluate Long-term Safety/ Tolerability of Dovitinib in Patients With Solid Tumors Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored Single Agent Dovitinib Studies Which Fulfilled the Requirements for the Primary Objective treatment 2 / 3 completed NCT02100007
ME-344 Given in Combination With Hycamtin® in Patients With Solid Tumors treatment 1 / 2 terminated NCT02095951
Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection treatment 4 completed NCT02096614
Investigator Initiated Phase 1 Study of TBI-1201 treatment 1 completed NCT02082626
Study of Eribulin in Children With Cancer to Determine Safety treatment 1 terminated NCT02078349
Phase I Study of KPT330 in Asian Patients treatment 1 completed NCT02071537
Chloroquine in Combination With Carboplatin/Gemcitabine in Advanced Solid Tumors treatment 1 completed NCT02065726
Whey Protein Supplementation in Cancer Patients No drug interventions treatment Not Available completed NCT02058901
Study of High-dose, Intermittent Sunitinib in Patients With Solid Tumors. treatment 1 completed NCT02048488
A Phase I/IIa Open-Label, Dose Escalation and Cohort Expansion Trial of Oral TSR-011 in Patients With Advanced Solid Tumors and Lymphomas No drug interventions treatment 1 / 2 completed NCT02045719
Phase II Clinical Trial of Uncaria Tomentosa (Cat´s Claw) in Patients With Advanced Solid Tumors No drug interventions supportive_care 2 unknown_status NCT02033551
A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors treatment 1 completed NCT02020226
A Cardiac Safety Study of TH-302 in Patients With Advanced Solid Tumors treatment 1 unknown_status NCT02004717
Phase 1 Study of DS-8895a in Subjects With Advanced Solid Tumors No drug interventions treatment 1 completed NCT01988896
Study of Atezolizumab in Combination With Cobimetinib in Participants With Locally Advanced or Metastatic Solid Tumors treatment 1 completed NCT01957007
A Study of Vantictumab (OMP-18R5) in Combination With Docetaxel in Patients With Previously Treated NSCLC treatment 1 completed NCT01955473
Japanese Phase 1 Trial of Sym004 in Solid Tumors treatment 1 completed NCT01949545
Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment other 1 completed NCT01949688
Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 or A*02-positive Advanced Solid Tumors No drug interventions treatment 1 / 2 completed NCT01943461
Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor JPN) treatment 1 completed NCT01930292
Debio 1143 in Combination With Carboplatin and Paclitaxel in Patient With Advanced Solid Malignancies treatment 1 terminated NCT01922752
To Determine the Maximum Tolerated Dose of Oral CEP-37440 in Patients With Advanced or Metastatic Solid Tumors treatment 1 completed NCT01910545
Phase 1 Study of OTS167 in Patients With Solid Tumors No drug interventions treatment 1 completed NCT01905228
A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm No drug interventions treatment 1 completed NCT01878890
Phase I Dose Escalation Trial of Efavirenz in Solid Tumours or Non-Hodgkin Lymphoma in Therapeutic Failure. treatment 1 completed NCT01877811
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors treatment 1 completed NCT01862328
Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Participants With Solid Tumors other 1 completed NCT01858883
Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid Tumors treatment 1 / 2 completed NCT01844583
Safety, Tolerability and Pharmacokinetic (PK) of Concomitant Esomeprazole and Rifampin, and QT Study on Single and Multiple-doses of Alisertib treatment 1 completed NCT01844661
Safety and Efficacy of Repeated Infusion of CELYVIR in Children and Adults With Metastatic and Refractory Tumors. No drug interventions treatment 1 / 2 completed NCT01844869
An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine Mepesuccinate treatment 1 completed NCT01832506
A Japanese Phase 1 Trial of c-Met Inhibitor MSC2156119J in Subjects With Solid Tumors treatment 1 completed NCT01822756
An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors treatment 1 terminated NCT01800812
Effects of OM-174 in Adult Patients With Solid Tumors No drug interventions Not Available 1 completed NCT01799083
Lower Dose Decitabine Based Therapy in Patients With Refractory and/or Chemotherapy Resistant Solid Tumors or B Cell Lymphomas treatment 1 / 2 unknown_status NCT01772004
Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor) treatment 1 completed NCT01770353
MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment other 1 completed NCT01748019
ST1968 Intravenous (Weekly) in Solid Tumors treatment 1 completed NCT01748825
AZD1775 for Advanced Solid Tumors treatment 1 completed NCT01724320
A Phase I, First-in-man Study of OTX008 Given Subcutaneously as a Single Agent to Patients With Advanced Solid Tumors treatment 1 unknown_status NCT01725555
A Study to Assess the Effect of Food on the Bioavailability of the IGF-1R Inhibitor AXL1717 in Patients With Advanced Malignant Tumors Not Available 1 completed NCT01711034
A Phase 1, Open-label, Multiple Dose Escalation Trial to Determine Safety and Tolerability of Once Daily OPB-111077 in Subjects With Advanced Cancer treatment 1 completed NCT01699061
Effect of Tivantinib on the QTC Interval in Cancer Subjects treatment 1 completed NCT01670097
Dexamethasone Dyspnea Study treatment 2 completed NCT01664000
A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors treatment 1 completed NCT01634555
A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRI treatment 2 completed NCT01624467
A Study of Necitumumab Monotherapy and the QT/QTc Interval in Patient With Advanced Solid Tumors treatment 2 completed NCT01617928
A Study of Veliparib in Combination With Carboplatin and Paclitaxel in Japanese Subjects With Solid Tumors treatment 1 completed NCT01608867
A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors treatment 1 completed NCT01602289
A Study of LY2875358 in Japanese Participants With Advanced Cancer treatment 1 completed NCT01593228
Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial treatment 3 completed NCT01581541
PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma That Have Not Responded to Standard Treatment treatment 1 terminated NCT01577745
A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI0639 in Advanced Solid Tumors No drug interventions treatment 1 completed NCT01574235
Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents Not Available Not Available completed NCT01568632
Imetelstat for Children With Refractory or Recurrent Solid Tumors and Lymphoma treatment 1 withdrawn NCT01553656
Dose-Finding Study of Cabozantinib (XL184) in Japanese Subjects With Advanced Cancer treatment 1 completed NCT01548924
Determination of Dose of Antiangiogenic Multitargeted DOVITINIB (TKI258) Plus Paclitaxel in Patients With Solid Tumors treatment 1 terminated NCT01544322
Dose Escalation Study of the Safety and Pharmacokinetics of ME-344 Single Agent for Refractory Solid Tumors treatment 1 completed NCT01538537
Safety of ON 01910.Na as a 3-day Infusion in Patients With Advanced Cancer treatment 1 completed NCT01538563
Safety of 24-Hour Infusion of ON 01910.Na in Patients With Advanced Cancer treatment 1 completed NCT01537744
A Trial of Oral 5-azacitidine in Combination With Romidepsin in Advanced Solid Tumors, With an Expansion Cohort in Virally Mediated Cancers and Liposarcoma treatment 1 completed NCT01532011
Erlotinib in Combination With Pralatrexate in Advanced Malignancies treatment 1 completed NCT01525602
Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors treatment 1 completed NCT01517399
Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects other 1 completed NCT01509300
HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors treatment 1 / 2 unknown_status NCT01505153
Phase I Intratumoral Pbi-shRNA STMN1 LP in Advanced and/or Metastatic Cancer No drug interventions treatment 1 completed NCT01504490
Phase I Study of CS-7017 and Bexarotene treatment 1 terminated NCT01502800
Clinical Trial of ARQ 761 in Advanced Solid Tumors No drug interventions treatment 1 completed NCT01501604
BKM120 in Cancers With PIK3CA Activating Mutations treatment 2 withdrawn NCT01490047
Single Dose of Intravenous rhTNF-α and Liposomal Doxorubicin in Patients With Advanced Solid Tumors or Lymphomas treatment 1 withdrawn NCT01485042
Dose Escalation Study of Pazopanib Plus TH-302 other 1 completed NCT01470209
A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies treatment 1 completed NCT01463696
Study of Safety and Pharmacokinetics of MK-8242 in Participants With Advanced Solid Tumors (P07650) No drug interventions treatment 1 terminated NCT01457417
A Study of DKN-01 in Multiple Myeloma or Advanced Solid Tumors treatment 1 completed NCT01453283
Tabectedin to Treat Children and Adolescents With Cancer treatment 1 completed NCT01447225
Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors treatment 1 completed NCT01445106
A Phase I Trial of Nelfinavir (Viracept ) in Adults With Solid Tumors treatment 1 completed NCT01443481
Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function treatment 1 completed NCT01444456
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia No drug interventions Not Available Not Available completed NCT01438554
Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma other 1 completed NCT01437280
GOAT; Phase I Open Label Study of CGTG-102, a GM-CSF Encoding Oncolytic Adenovirus, for Advanced Cancers treatment 1 withdrawn NCT01431534
A Study of Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-056) treatment 1 terminated NCT01431547
Study of Dalotuzumab Alone and With Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-062 AM1) treatment 1 completed NCT01415297
Dose Escalation Study of NKP-1339 to Treat Advanced Solid Tumors treatment 1 completed NCT01401868
Phase I Dose Escalation Study of the Safety and Pharmacokinetics of ME-143 Single Agent for Refractory Solid Tumors No drug interventions treatment 1 completed NCT01369433
A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols treatment Not Available terminated NCT01362985
Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor No drug interventions Not Available Not Available completed NCT01358019
A Study of LY2523355 in Patients With Solid Cancer treatment 1 completed NCT01349296
BIBF 1120 and RAD001 in Solid Tumors - Phase I treatment 1 completed NCT01345513
Feasibility Clinical Study of Targeted and Genome-Wide Sequencing No drug interventions Not Available Not Available completed NCT01345201
A Dose Escalation Study of OMP-18R5 in Subjects With Solid Tumors treatment 1 completed NCT01341457
A Study of LY2603618 in Combination With Gemcitabine in Participants With Solid Tumors treatment 1 completed NCT01336842
Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid Tumors treatment 1 completed NCT01327612
Open Label Extension Study of Conatumumab and Ganitumab (AMG 479) treatment 2 completed NCT01324479
Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors treatment 1 completed NCT01313598
GLPG0187: Safety, Tolerability and Pharmacokinetics in Patients With Solid Tumors treatment 1 completed NCT01300533
A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer No drug interventions treatment 1 completed NCT01299636
Study of PM060184 in Patients With Advanced Solid Tumors Not Available 1 completed NCT01299415
Safety and Pharmacokinetics of ASA404 When Given Together With Fluvoxamine, a Selective Serotonin Receptor Reuptake Inhibitor and CYP1A2 Inhibitor treatment 1 terminated NCT01297452
BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors treatment 1 completed NCT01295697
Study of EZN-2208 Pediatric Patients With Solid Tumors treatment 1 / 2 terminated NCT01294670
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors treatment 1 / 2 completed NCT01279603
Study of GO-203-2C Given Intravenously in Patients With Advanced Solid Tumors Including Lymphomas treatment 1 completed NCT01275612
Mesenchymal Stem Cells In Cisplatin-Induced Acute Renal Failure In Patients With Solid Organ Cancers No drug interventions treatment 1 withdrawn NCT01253837
L19TNFα in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 completed NCT01246102
AT13387 in Adults With Refractory Solid Tumors treatment 1 completed NCT01245543
Safety Study for Intravenous (IV) AC480 (AC480IV) to Treat Advanced Solid Tumors treatment 1 withdrawn NCT01240655
A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors treatment 1 completed NCT01222637
CetuGEXâ„¢: Phase 1 Study in Cancer Patients treatment 1 completed NCT01212341
Allogeneic Natural Killer (NK) Cell Therapy in Patients With Lymphoma or Solid Tumor treatment 1 completed NCT01199224
To Determine the Food Effect and Bioavailability of Three Formulations of Veliparib in Subjects With Solid Tumors treatment 1 completed NCT01197170
Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance treatment 1 completed NCT01170975
Effects of Food on the Pharmacokinetics of Tesetaxel 10 mg Capsules No drug interventions Not Available 1 completed NCT01168752
Study of Debio 0932 in Patients With Advanced Solid Tumours or Lymphoma No drug interventions treatment 1 completed NCT01165385
Study With Pazopanib in Combination With Cisplatin (CDDP) in Patients With Advanced Solid Tumors treatment 1 completed NCT01158079
Multi-center, Open Label, Extension Study of ALN-VSP02 in Cancer Patients Who Have Responded to ALN-VSP02 Treatment No drug interventions treatment 1 completed NCT01151384
Liposome Encapsulated Docetaxel (LE-DT) in Patients With Solid Tumors treatment 1 completed NCT01129349
Phase 1 Study of Oprozomib Administered Orally in Patients With Advanced Refractory or Recurrent Solid Tumors treatment 1 completed NCT01127178
Study of Poly (ADP-Ribose) Polymerase (PARP) Inhibitor E7016 in Combination With Temozolomide in Subjects With Advanced Solid Tumors treatment 1 completed NCT01121133
A Study to Assess the Effect of Rifampin on the Metabolism of Navitoclax treatment 1 completed NCT01114191
A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifanib (ABT-869) basic_science 1 completed NCT01110083
First-in-Man, Dose-escalation Trial of c-Met Kinase Inhibitor EMD 1204831 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT01078649
Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas treatment 1 completed NCT01072890
Temsirolimus and Pazopanib in Patients With Advanced Solid Tumors treatment 1 completed NCT01071018
A Study of MK2206 in Locally Advanced or Metastatic Solid Tumors (2206-007) No drug interventions treatment 1 completed NCT01062620
A Dose Escalating Clinical Trial of the IGF-1 Receptor Inhibitor AXL1717 in Patients With Advanced Cancer treatment 1 completed NCT01050413
Evaluation of Thymidine Kinase Activity in the Serum of Patients With Solid Tumors No drug interventions Not Available Not Available unknown_status NCT01049893
Dose Finding, Safety and Tolerability Study for AC220 to Treat Advanced Solid Tumors treatment 1 completed NCT01009073
A Study Evaluating ABT-263 With Erlotinib, ABT-263 With Irinotecan, and ABT-263 Monotherapy in Cancer Subjects treatment 1 completed NCT00996892
Safety, Tolerability and Pharmacokinetics of Cobimetinib in Combination With Pictilisib in Patients With Locally Advanced or Metastatic Solid Tumors treatment 1 terminated NCT00984425
The Treatment of Lapatinib in Combination With Sorafenib in Patients With Advanced Refractory Solid Tumors treatment 1 completed NCT00982566
Assess the Oral Bioavailability of a New ABT-263 Formulation in Subjects With Cancer treatment 1 completed NCT00982267
A Trial Of SU14813 In Patients With Advanced Solid Malignancies No drug interventions treatment 1 completed NCT00978523
Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma No drug interventions treatment 1 completed NCT00977210
Safety Study of OXi4503 (a Vascular Disrupting Agent) Given by 3 x Weekly Intravenous Infusions to Patients With Advanced Solid Tumors treatment 1 completed NCT00973076
Study to Assess the Safety and Tolerability of the Tor Kinase Inhibitor AZD8055 treatment 1 completed NCT00970411
Study of KRN951 in Patients With Solid Tumors treatment 1 completed NCT00960063
A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006) treatment 1 terminated NCT00949559
Pharmacodynamics (PD) and Pharmacokinetics (PK) Study of EP-100 in Advanced Solid Tumors treatment 1 completed NCT00942799
Dose Escalation Study to Assess the Safety and Tolerability of Genz-644282 in Patients With Solid Tumors No drug interventions treatment 1 completed NCT00925275
Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors basic_science 1 completed NCT00921869
A Study of E7050 Administered Orally to Patients With Advanced Solid Tumors treatment 1 completed NCT00918320
Studies of Temozolomide in Combination With Topotecan in Refractory and Relapsed Paediatric Solid Tumours treatment 2 completed NCT00918281
Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection diagnostic 2 completed NCT00909207
Patient-Reported Outcomes Version of Common Terminology Criteria (CTCPRO) Cognitive Debriefing No drug interventions Not Available Not Available completed NCT00891605
Safety Study of ABT-263 in Combination With Paclitaxel in Subjects With Solid Tumors treatment 1 completed NCT00889382
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors) treatment 1 / 2 completed NCT00884312
A Study of Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment Protocols treatment 2 completed NCT00882180
Dose Escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous ALN-VSP02 In Patients With Advanced Solid Tumors With Liver Involvement No drug interventions treatment 1 completed NCT00878111
Study of NGR-hTNF Administered at High Doses in Patient With Advanced or Metastatic Solid Tumour treatment 1 completed NCT00878449
A Study Evaluating the Safety of ABT-263 in Combination With Etoposide/Cisplatin in Subjects With Cancer treatment 1 completed NCT00871910
Phase 1 Every-3-Week Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04630) treatment 1 completed NCT00869388
A Phase I Study of Bi-Weekly rBBX-01 in Patients With Solid Tumors No drug interventions treatment 1 completed NCT00863733
Study of DMXAA (Now Known as ASA404) in Solid Tumors treatment 1 completed NCT00858377
A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors No drug interventions treatment 1 completed NCT00847366
Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma treatment Not Available completed NCT00839631
Dose Escalation Study of EC D-3263 HCl in Advanced Solid Tumors No drug interventions treatment 1 completed NCT00818831
A Study of QBI-139 in Subjects With Advanced Solid Tumors No drug interventions Not Available 1 unknown_status NCT00819221
AZD2281 in Combination With Liposomal Doxorubicin in Advanced Solid Tumours treatment 1 terminated NCT00807859
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer treatment 1 completed NCT00805636
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy. diagnostic 2 unknown_status NCT00801177
Study of IMC-11F8 in Patients With Tumors Who Have Not Responded to Standard Therapy Not Available 1 completed NCT00798889
Rollover Protocol for Prior SU011248 Protocols treatment Not Available completed NCT00791063
18F ML-10 for Early Detection of Response of Brain Metastases to WBRT No drug interventions diagnostic 2 completed NCT00778128
A Phase I Clinical Study of Oral CP-4126 in Patients With Advanced Solid Tumour treatment 1 completed NCT00776867
Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors treatment 1 completed NCT00773929
Safety Study of TAK-593 Given Orally in Subjects With Nonhematologic Advanced Cancer treatment 1 completed NCT00773344
Clinical Trial of the Combination of Trastuzumab (Herceptin) and Tanespimycin in Patients With Solid Tumors and Her2 Positive Metastatic Breast Cancer That Have Previously Failed Herceptin treatment 1 / 2 completed NCT00770536
AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR treatment 1 completed NCT00770263
Erlotinib and Temsirolimus for Solid Tumors treatment 1 completed NCT00768391
Study of IMC-3G3 in Patients With Tumors That Are Not Responding to Standard Therapies or No Therapy is Available Not Available 1 completed NCT00765973
Topotecan Liposomes Injection for Small Cell Lung Cancer (SCLC), Ovarian Cancer and Other Advanced Solid Tumors treatment 1 completed NCT00752011
Phase I Study of TAS-106 in Combo With Carboplatin treatment 1 completed NCT00749502
A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8) treatment 1 completed NCT00750126
Allogeneic Hematopoietic Stem Cell Transplantation treatment 2 unknown_status NCT00744562
A Phase 1 Dose Escalation Study of OMP-21M18 in Subjects With Solid Tumors No drug interventions treatment 1 completed NCT00739609
IDO Inhibitor Study for Relapsed or Refractory Solid Tumors treatment 1 terminated NCT00732836
Hepatic Arterial Infusion (HAI) of Abraxane treatment 1 completed NCT00733031
Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD6918 treatment 1 terminated NCT00731263
A Study of Tor Kinase Inhibitor in Advanced Tumors treatment 1 completed NCT00720148
A Phase I Trial of Bortezomib and Sunitinib treatment 1 completed NCT00716287
Characterisation of Gene Variants in the Angiogenic Pathway No drug interventions Not Available Not Available unknown_status NCT00710697
Cardiac Safety Assessment Study of Picoplatin in Solid Tumors treatment 1 unknown_status NCT00704054
A Multi-Center Phase I Study of Intravenous Deforolimus (AP23573, MK-8669) Administered QDX5 Every Other Week in Pediatric Patients With Advanced Solid Tumors (8669-028)(COMPLETED) treatment 1 completed NCT00703378
Target Dosing of Docetaxel Through Pharmacokinetic/Pharmacodynamic Optimisation of the First Chemotherapeutic Cycle treatment 1 / 2 completed NCT00702494
Phase I Study on Monoclonal Antibody TB-403 Directed Against PlGF in Patients With Solid Tumours No drug interventions treatment 1 completed NCT00700336
Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II) treatment 1 / 2 completed NCT00697437
Effect of Ketoconazole Inhibition of CYP3A on Urinary Excretion of Docetaxel treatment 2 completed NCT00687934
Study of STA-9090, Administered Once-Weekly in Patients With Solid Tumors treatment 1 completed NCT00674947
A Phase I Study of BIIB015 in Relapsed/Refractory Solid Tumors treatment 1 completed NCT00667147
Phase I Abraxane Weekly and Three Weekly Schedule With Vandetanib treatment 1 completed NCT00661414
Safety Study of ASONEP (Sonepcizumab/LT1009) to Treat Advanced Solid Tumors treatment 1 completed NCT00660426
Study Of Advanced Gastrointestinal Malignancies And Other Solid Tumors treatment 1 completed NCT00658658
Panitumumab in Children With Solid Tumors treatment 1 completed NCT00658970
Evaluation of KX2-391 in Patients With Advanced Malignancies treatment 1 completed NCT00636545
Genasense as a 2-hour Intravenous Infusion in Subjects With Solid Tumors treatment 1 completed NCT00635596
Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer No drug interventions treatment 1 completed NCT00628732
A Pharmacokinetic Study of Oral Cyclophosphamide and Topotecan in Children With Recurrent Solid Tumors treatment 2 completed NCT00629200
Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced Malignancies treatment 1 completed NCT00615446
A Study To Find The Best Doses Of SU011248 And Gemcitabine When Given Together To Patients With Advanced Solid Tumors treatment 1 completed NCT00613847
Biodistribution and Dosimetry of Serial PET Imaging With Ga-68 Labeled F(ab') 2- Trastuzumab No drug interventions diagnostic 1 completed NCT00611689
Imatinib and PTK787/ZK222584 in Refractory and/or Advanced Solid Tumors treatment 1 completed NCT00606437
Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants No drug interventions treatment 1 completed NCT00600275
A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer No drug interventions treatment 1 / 2 completed NCT00601133
Function and Balance for Inpatient Rehabilitation No drug interventions Not Available Not Available completed NCT00591682
MSX-122 Administered Orally in Patients With Refractory Metastatic or Locally Advanced Solid Tumors treatment 1 suspended NCT00591396
A Phase I Trial of ZIO-101 in Solid Tumors treatment 1 completed NCT00591136
Phase I Study of Indibulin in Patients With Solid Tumors treatment 1 completed NCT00586092
A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tumors Not Available 1 completed NCT00586560
Karenitecin in Pediatric Patients With Refractory or Recurrent Solid Tumors N10010) treatment 1 completed NCT00578942
Allo Non-myeloablative SCT Utilizing Matched Family Member Stem Cells Purged Using Campath treatment 2 completed NCT00580034
Allo Non-Myeloablative SCT Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath treatment 2 completed NCT00572078
Sorafenib and Bevacizumab in Combination With Paclitaxel in Patients With Solid Tumors treatment 1 completed NCT00572637
Phase I Study of the Proteosome Inhibitor CEP 18770 in Patients With Solid Tumours or Non-Hodgkin's Lymphomas treatment 1 completed NCT00569036
Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors treatment 1 completed NCT00560716
A Phase I Pharmacologic Study of CYC116, an Oral Aurora Kinase Inhibitor, in Patients With Advanced Solid Tumors treatment 1 terminated NCT00556088
LBH589, Paclitaxel, Carboplatin +/- Bevacizumab for Solid Tumors treatment 1 completed NCT00552825
Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children No drug interventions Not Available Not Available completed NCT00553189
Safety Study of ABT-888 Plus Topotecan Hydrochloride to Treat Patients With Solid Tumors and Lymphomas treatment 1 completed NCT00550199
LBH589 and Gemcitabine in the Treatment of Solid Tumors treatment 1 terminated NCT00540384
Dose-finding Study of Novel Erythropoiesis Stimulating Protein (NESP) for the Treatment of Anaemia in Subjects With Solid Tumours Receiving Multicycle Chemotherapy treatment 1 / 2 completed NCT00531284
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma treatment 1 / 2 completed NCT00529022
Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer treatment 1 completed NCT00511017
Doxercalciferol in Recurrent Pediatric Solid Tumors treatment 1 terminated NCT00508807
RTA 402 in Advanced Solid Tumors or Lymphoid Malignancies treatment 1 completed NCT00500422
Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients treatment 1 completed NCT00497731
AZD1152 in Patients With Advanced Solid Malignancies-Study 1 treatment 1 terminated NCT00483093
Study of NGR-hTNF in Combination With Cisplatin in Solid Tumor treatment 1 completed NCT00460278
Study of XL418 in Adults With Solid Tumors treatment 1 suspended NCT00448786
Effect of Different Doses of AMG 706 on the Gallbladder in Advanced Solid Tumors treatment 1 completed NCT00442741
Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension) treatment 1 withdrawn NCT00428545
Bevacizumab and Bortezomib in Patients With Advanced Malignancy treatment 1 completed NCT00424632
Phase 1 Study Of Aurora Kinase Inhibitor PF-03814735 In Patients With Advanced Solid Tumors treatment 1 completed NCT00420485
Dose-escalation Study of Gimatecan Administered in Two Different Schedules in Adult Patients With Advanced Solid Tumors treatment 1 completed NCT00420615
Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies treatment 1 completed NCT00413283
Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC) supportive_care 2 completed NCT00413686
Study to Assess Safety of AZD7762 Administered Alone and in Combination With Gemcitabine in Patients With Advanced Solid Malignancies treatment 1 completed NCT00390936
A Study of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors treatment 1 completed NCT00360867
An Open Label Treatment Extension Study of AMG 706 treatment 2 terminated NCT00322140
CDDO to Treat Solid Tumors and Lymphomas No drug interventions treatment 1 completed NCT00278018
Peritumoral Injection of Immature Dendritic Cells to Irradiated Skin Metastases of Solid Tumors No drug interventions treatment 1 / 2 terminated NCT00249977
Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan treatment 1 completed NCT00192777
Concurrent Xeloda and Radiotherapy for Bone Metastases treatment 2 unknown_status NCT00165373
rhEndostatin Protein Involving Pediatric Patients With Cancer No drug interventions treatment 1 terminated NCT00100347
Safety/Tolerance Study of PPI-2458 in Subjects With Non-Hodgkin's Lymphoma and Solid Tumors treatment 1 terminated NCT00091806
Two Dose Schedules of Panitumumab in Subjects With Advanced Solid Tumors treatment 1 completed NCT00044785
Phase I Study of PN401, Fluorouracil, Leucovorin and CPT-11 in Patients With Solid Tumors treatment 1 terminated NCT00033215
A Phase 1 Study of S-3304 in Patients With Solid Tumors treatment 1 completed NCT04937686
A Phase I Trial of ProAgio, an Anti- Alpha-v-beta3 Integrin Cytotoxin, for Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies No drug interventions treatment 1 not_yet_recruiting NCT04692662
Talazoparib, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Aberrations in Genes Involved in DNA Damage Response treatment 2 recruiting NCT01479309
Study to Evaluate Sodium Stibogluconate With Interferon Alpha-2b treatment 2 withdrawn